
    <!doctype html>
    
    <html lang="en" class="no-js">
    <head>
        <meta charset="utf-8">
        <title>Know Your Vaccine - Pfizer: Skin &amp; localized to injection site</title>
        <meta name="description" content="Search Covid19 vaccine adverse effects as reported by the CDC">
        <meta name="author" content="Silvia Gheorghita, Dane Harrigan">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">

        <script>
            document.documentElement.className = document.documentElement.className.replace(/\bno-js\b/g, '') + ' js ';
        </script>

        
        <link rel="stylesheet" href="/assets/css/main.css">
        <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@5/css/all.min.css">
        <style>
            .full-width {
                width: 100%;
            }

            .no-padding-right {
                padding-right: 0;
            }

            .toc__menu ul {
                display: none;
            }
            .toc__menu .category-open {
                display: block;
            }

            table td {
                position: relative;
            }
            .full-notes {
                display: none;
                border: 1px solid #CCC;
                background: #FFF;
                box-shadow: 0 0 10px #CCC;
                padding: 10px;

                position: absolute;
                top: 0;
                right: 0;
                z-index: 100;
                height: 250px;
                width: 470px;
                overflow: scroll;
            }

            .open-notes .full-notes {
                display: block;
            }

            .close-notes-bar {
                text-align: right;
            }

            .clear {
                clear: both;
            }

            .sidebar__right {
                position: relative;
                float: right;
            }

            @media (max-width:600px) {
                .full-notes {
                    width: 100%;
                }
                .page__content h2 {
                    clear: both;
                }
            }
        </style>
        
    </head>

    
    <script async src="https://www.googletagmanager.com/gtag/js?id=G-FS69Z1WR2E"></script>
    <script>
        window.dataLayer = window.dataLayer || [];
        function gtag(){dataLayer.push(arguments);}
        gtag('js', new Date());

        gtag('config', 'G-FS69Z1WR2E');
    </script>

    <body class="layout--splash">
    <nav class="skip-links">
        <h2 class="screen-reader-text">Skip links</h2>
        <ul>
            <li><a href="#site-nav" class="screen-reader-shortcut">Skip to primary navigation</a></li>
            <li><a href="#main" class="screen-reader-shortcut">Skip to content</a></li>
            <li><a href="#footer" class="screen-reader-shortcut">Skip to footer</a></li>
        </ul>
    </nav>
    <div class="masthead">
        <div class="masthead__inner-wrap">
            <div class="masthead__menu">
                <nav id="site-nav" class="greedy-nav">
                    <a class="site-title" href="/">
                        KnowYourVaccine.org
                        <span class="site-subtitle">An unbiased view of Covid19 vaccine adverse effects</span>
                    </a>
                    <ul class="visible-links">
                        <li class="masthead__menu-item">
                            <a href="/about/">About</a>
                        </li>
                    </ul>
                    <button class="greedy-nav__toggle hidden" type="button">
                        <span class="visually-hidden">Toggle menu</span>
                        <div class="navicon"></div>
                    </button>
                </nav>
            </div>
        </div>
    </div>


<div class="initial-content">
    <div id="main" role="main">
        <article class="page full-width">
            <div class="page__inner-wrap">
                <header>
                    <h1 id="page-title" class="page__title" itemprop="headline">Pfizer</h1>
                </header>
                <section class="page__content" itemprop="text">
                    <aside class="sidebar__right ">
                        <nav class="toc">
                            <header><h4 class="nav__title">Symptoms reported</h4></header>
                            <ul class="toc__menu">
                                
                                
                                    <li>
                                        <a href="#" class="category-toggle">Cardiovascular reports: 11,627</a>
                                        <ul>
                                            <li><a href="/vaccine/pfizer/category/cardiovascular/female/16/25/">Female 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/cardiovascular/female/26/39/">Female 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/cardiovascular/female/40/59/">Female 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/cardiovascular/female/60/75/">Female 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/cardiovascular/female/76/89/">Female 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/cardiovascular/female/90/110/">Female 90+ years</a></li>
                                            <li><a href="/vaccine/pfizer/category/cardiovascular/male/16/25/">Male 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/cardiovascular/male/26/39/">Male 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/cardiovascular/male/40/59/">Male 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/cardiovascular/male/60/75/">Male 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/cardiovascular/male/76/89/">Male 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/cardiovascular/male/90/110/">Male 90+ years</a></li>
                                        </ul>
                                    </li>
                                
                                    <li>
                                        <a href="#" class="category-toggle">Eyes, mouth &amp; ears reports: 2,885</a>
                                        <ul>
                                            <li><a href="/vaccine/pfizer/category/eyes-mouth-and-ears/female/16/25/">Female 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/eyes-mouth-and-ears/female/26/39/">Female 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/eyes-mouth-and-ears/female/40/59/">Female 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/eyes-mouth-and-ears/female/60/75/">Female 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/eyes-mouth-and-ears/female/76/89/">Female 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/eyes-mouth-and-ears/female/90/110/">Female 90+ years</a></li>
                                            <li><a href="/vaccine/pfizer/category/eyes-mouth-and-ears/male/16/25/">Male 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/eyes-mouth-and-ears/male/26/39/">Male 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/eyes-mouth-and-ears/male/40/59/">Male 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/eyes-mouth-and-ears/male/60/75/">Male 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/eyes-mouth-and-ears/male/76/89/">Male 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/eyes-mouth-and-ears/male/90/110/">Male 90+ years</a></li>
                                        </ul>
                                    </li>
                                
                                    <li>
                                        <a href="#" class="category-toggle">Flu-like reports: 37,261</a>
                                        <ul>
                                            <li><a href="/vaccine/pfizer/category/flu-like/female/16/25/">Female 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/flu-like/female/26/39/">Female 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/flu-like/female/40/59/">Female 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/flu-like/female/60/75/">Female 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/flu-like/female/76/89/">Female 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/flu-like/female/90/110/">Female 90+ years</a></li>
                                            <li><a href="/vaccine/pfizer/category/flu-like/male/16/25/">Male 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/flu-like/male/26/39/">Male 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/flu-like/male/40/59/">Male 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/flu-like/male/60/75/">Male 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/flu-like/male/76/89/">Male 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/flu-like/male/90/110/">Male 90+ years</a></li>
                                        </ul>
                                    </li>
                                
                                    <li>
                                        <a href="#" class="category-toggle">Gastrointestinal reports: 8,034</a>
                                        <ul>
                                            <li><a href="/vaccine/pfizer/category/gastrointestinal/female/16/25/">Female 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/gastrointestinal/female/26/39/">Female 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/gastrointestinal/female/40/59/">Female 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/gastrointestinal/female/60/75/">Female 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/gastrointestinal/female/76/89/">Female 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/gastrointestinal/female/90/110/">Female 90+ years</a></li>
                                            <li><a href="/vaccine/pfizer/category/gastrointestinal/male/16/25/">Male 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/gastrointestinal/male/26/39/">Male 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/gastrointestinal/male/40/59/">Male 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/gastrointestinal/male/60/75/">Male 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/gastrointestinal/male/76/89/">Male 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/gastrointestinal/male/90/110/">Male 90+ years</a></li>
                                        </ul>
                                    </li>
                                
                                    <li>
                                        <a href="#" class="category-toggle">Immune system reports: 9,703</a>
                                        <ul>
                                            <li><a href="/vaccine/pfizer/category/immune-system/female/16/25/">Female 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/immune-system/female/26/39/">Female 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/immune-system/female/40/59/">Female 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/immune-system/female/60/75/">Female 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/immune-system/female/76/89/">Female 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/immune-system/female/90/110/">Female 90+ years</a></li>
                                            <li><a href="/vaccine/pfizer/category/immune-system/male/16/25/">Male 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/immune-system/male/26/39/">Male 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/immune-system/male/40/59/">Male 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/immune-system/male/60/75/">Male 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/immune-system/male/76/89/">Male 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/immune-system/male/90/110/">Male 90+ years</a></li>
                                        </ul>
                                    </li>
                                
                                    <li>
                                        <a href="#" class="category-toggle">Life threatening reports: 3,268</a>
                                        <ul>
                                            <li><a href="/vaccine/pfizer/category/life-threatening/female/16/25/">Female 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/life-threatening/female/26/39/">Female 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/life-threatening/female/40/59/">Female 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/life-threatening/female/60/75/">Female 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/life-threatening/female/76/89/">Female 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/life-threatening/female/90/110/">Female 90+ years</a></li>
                                            <li><a href="/vaccine/pfizer/category/life-threatening/male/16/25/">Male 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/life-threatening/male/26/39/">Male 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/life-threatening/male/40/59/">Male 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/life-threatening/male/60/75/">Male 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/life-threatening/male/76/89/">Male 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/life-threatening/male/90/110/">Male 90+ years</a></li>
                                        </ul>
                                    </li>
                                
                                    <li>
                                        <a href="#" class="category-toggle">Muscles &amp; bones reports: 9,029</a>
                                        <ul>
                                            <li><a href="/vaccine/pfizer/category/muscles-and-bones/female/16/25/">Female 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/muscles-and-bones/female/26/39/">Female 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/muscles-and-bones/female/40/59/">Female 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/muscles-and-bones/female/60/75/">Female 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/muscles-and-bones/female/76/89/">Female 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/muscles-and-bones/female/90/110/">Female 90+ years</a></li>
                                            <li><a href="/vaccine/pfizer/category/muscles-and-bones/male/16/25/">Male 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/muscles-and-bones/male/26/39/">Male 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/muscles-and-bones/male/40/59/">Male 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/muscles-and-bones/male/60/75/">Male 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/muscles-and-bones/male/76/89/">Male 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/muscles-and-bones/male/90/110/">Male 90+ years</a></li>
                                        </ul>
                                    </li>
                                
                                    <li>
                                        <a href="#" class="category-toggle">Nervous system reports: 18,808</a>
                                        <ul>
                                            <li><a href="/vaccine/pfizer/category/nervous-system/female/16/25/">Female 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/nervous-system/female/26/39/">Female 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/nervous-system/female/40/59/">Female 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/nervous-system/female/60/75/">Female 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/nervous-system/female/76/89/">Female 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/nervous-system/female/90/110/">Female 90+ years</a></li>
                                            <li><a href="/vaccine/pfizer/category/nervous-system/male/16/25/">Male 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/nervous-system/male/26/39/">Male 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/nervous-system/male/40/59/">Male 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/nervous-system/male/60/75/">Male 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/nervous-system/male/76/89/">Male 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/nervous-system/male/90/110/">Male 90+ years</a></li>
                                        </ul>
                                    </li>
                                
                                    <li>
                                        <a href="#" class="category-toggle">Psychological reports: 3,816</a>
                                        <ul>
                                            <li><a href="/vaccine/pfizer/category/psychological/female/16/25/">Female 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/psychological/female/26/39/">Female 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/psychological/female/40/59/">Female 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/psychological/female/60/75/">Female 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/psychological/female/76/89/">Female 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/psychological/female/90/110/">Female 90+ years</a></li>
                                            <li><a href="/vaccine/pfizer/category/psychological/male/16/25/">Male 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/psychological/male/26/39/">Male 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/psychological/male/40/59/">Male 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/psychological/male/60/75/">Male 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/psychological/male/76/89/">Male 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/psychological/male/90/110/">Male 90+ years</a></li>
                                        </ul>
                                    </li>
                                
                                    <li>
                                        <a href="#" class="category-toggle">Skin &amp; localized to injection site reports: 12,017</a>
                                        <ul>
                                            <li><a href="/vaccine/pfizer/category/skin-and-localized-to-injection-site/female/16/25/">Female 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/skin-and-localized-to-injection-site/female/26/39/">Female 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/skin-and-localized-to-injection-site/female/40/59/">Female 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/skin-and-localized-to-injection-site/female/60/75/">Female 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/skin-and-localized-to-injection-site/female/76/89/">Female 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/skin-and-localized-to-injection-site/female/90/110/">Female 90+ years</a></li>
                                            <li><a href="/vaccine/pfizer/category/skin-and-localized-to-injection-site/male/16/25/">Male 16 - 25 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/skin-and-localized-to-injection-site/male/26/39/">Male 26 - 39 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/skin-and-localized-to-injection-site/male/40/59/">Male 40 - 59 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/skin-and-localized-to-injection-site/male/60/75/">Male 60 - 75 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/skin-and-localized-to-injection-site/male/76/89/">Male 76 - 89 years</a></li>
                                            <li><a href="/vaccine/pfizer/category/skin-and-localized-to-injection-site/male/90/110/">Male 90+ years</a></li>
                                        </ul>
                                    </li>
                                
                            </ul>
                        </nav>
                    </aside>

                    

                        <h2 id="default-layout">Skin &amp; localized to injection site symptom reports</h2>
                        

                        <h3 class="notice--info" id="table-of-contents">Male, 76 - 89 years </h3>

                        <table>
                            <thead>
                            <tr>
                            <th>Age</th>
                            <th>Reported</th>
                            <th>Symptoms</th>
                            <th>Notes</th>
                            </tr>
                            </thead>
                            <tbody>
                            
                                <tr>
                                    <td>76</td>
                                    <td>2021-01-05</td>
                                    <td><strong>rash</strong></td>
                                    <td>
                                        DEVELOPED RASH ON NECK AND SHOULDERS. RECEIVED 25MG DIPHENHYDRAMINE BY MOUTH AT 10:15AM. RASH RESOLV...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                DEVELOPED RASH ON NECK AND SHOULDERS. RECEIVED 25MG DIPHENHYDRAMINE BY MOUTH AT 10:15AM. RASH RESOLVED BY 10:30AM
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>76</td>
                                    <td>2021-01-25</td>
                                    <td><strong>skin spots</strong></td>
                                    <td>
                                        I write today because On January 20, I received my first Pfizer covid vaccination. I have felt no si...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                I write today because On January 20, I received my first Pfizer covid vaccination. I have felt no side effects but when I read the story of the doctor who died of bleeding after that vaccination, I became concerned because I do get minor petechiae from the blood thinner and then yesterday (1/25) I noticed a petechiae different from the rest. It was on my back and was bigger than the few tiny pinpoint ones from the medication.  I am wondering if the vaccine made the difference and if my platelet count is going down. Is it possible that the vaccine might interact with blood thinners and create Thrombocytopenia? I have never heard of that disease before, but I think it can exist unknown or maybe be started by the vaccine. I will be watching for any additional petechiae, but would it be good to get a platelet test to see if something has gone wrong? The doctor with zero platelets, no symptoms and death by bleeding has caused me concern and if blood thinners, my eczema or undiagnosed Thrombocytopenia cause issues for vaccines, that information would be good to know. I am a 76 year old male in generally good health. My fitbit walking target is at least 4 miles/day and I usually reach that. At 5? 9? and 172 pounds I enjoy golf weekly when winter is over. Two issues do exist. Twenty seven months ago while searching for the cause of some PVCs the doctors put in a stent and scarred a diagonal artery causing what they said was a heart attack. Recovery was quick and subsequent tests indicate the heart was healed and working fine. I have no heart symptoms, but since then have been on first Brillinta and now Clopidorgrel (Plavix) plus baby aspirin. Second, last August I was diagnosed with eczema which might be psoriasis which I think is autoimmune related.  It is annoying at times but the prescription cream helps.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>76</td>
                                    <td>2021-01-25</td>
                                    <td><strong>vaccination site pain</strong></td>
                                    <td>
                                        Weak; Chills and completely ice cold; Chills and completely ice cold; Really sore in injection arm; ...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Weak; Chills and completely ice cold; Chills and completely ice cold; Really sore in injection arm; Joints hurt; This is a spontaneous report from a contactable consumer (patient). This 76-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 11Jan2021 12:00 on arm Left at single dose for covid-19 immunisation. Lot number is EL3, then a number he cannot read, followed by 46. Medical history included type 2 diabetic. No concomitant medications. His joints hurt on 11Jan2021 in later afternoon. It is not worse, but not better. On 12Jan2021, chills and Woke up during night completely ice cold. Had to get a blanket and finally went back to sleep. Feels weak.  Doesn&#39;t know what happened. Still feels chill. After midnight on the 12Jan2021. Is a little bit better. He was really sore in injection arm on 11Jan2021. Outcome of the event Joints hurt was not recovered. Outcome of the events Chills and completely ice cold was recovering. Outcome of the event Really sore in injection arm was not recovered. Outcome of the event Weak was unknown.  Information about lot/batch number has been requested.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>76</td>
                                    <td>2021-02-17</td>
                                    <td><strong>tingling</strong></td>
                                    <td>
                                        dizzy; nauseous; left arm weakness/left leg weakness; numbness and tingling of his left fingers; num...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                dizzy; nauseous; left arm weakness/left leg weakness; numbness and tingling of his left fingers; numbness and tingling of his left fingers; lost balance; fell; This is a spontaneous report from a contactable physician. A 76-year-old male patient received 76-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; brand: Pfizer; lot number: 59267-1000-1) intramuscular at left arm on 02Feb2021 at 11:00AM at a single dose for COVID-19 immunization. Medical history included closed fracture of patella, coronary atherosclerosis, essential hypertension, malignant neoplasm of prostate, and known allergies: acetominophen, doxycycline, oxycodone-acetominophen, oxycodone hydrochloride/oxycodone terephthalate/paracetamol (PERCOCET). Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; brand: Pfizer, lot number: 59267-1000-1) intramuscularly at left arm on 12Jan2021 at 12:00PM for COVID-19 immunization. Other medications in two weeks included omeprazole (PRILOSEC, strength: 20 mg), CPD losartan potassium (COZAAR, 25 mg, tablet), simvastatin (strength: 20 mg, tabs), hydrochlorothiazide (strength: 25 mg, tabs). No other vaccine in four weeks. Facility type vaccine was at Doctor&#39;s office/urgent care. Adverse events were reported as follows: 20min after getting the 2nd dose, the patient became dizzy and nauseous. 20 min after that the patient developed left arm weakness and numbness and tingling of his left fingers. When trying to get out of his car, he lost balance and fell. He had no loss of consciousness or head trauma. He had progressively worsening left arm and left leg weakness. Adverse event start date was reported on 02Feb2021 at 11:30AM. AE resulted in Emergency room/department or urgent care, hospitalization for 3 days. Treatment received for AE included baclofen and methylprednisolone. The outcome of events was not recovered. No covid prior vaccination. Covid tested post vaccination included Nasal Swab (NAAT) on 02Feb2021 was negative.; Sender&#39;s Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>76</td>
                                    <td>2021-02-21</td>
                                    <td><strong>hives, itchy skin</strong></td>
                                    <td>
                                        Patient had itching after the 2nd dose Pfizer vaccine was given.  Given diphenhydramine 25 mg PO. Pa...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Patient had itching after the 2nd dose Pfizer vaccine was given.  Given diphenhydramine 25 mg PO. Patient had reported hives after first dose.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>76</td>
                                    <td>2021-02-23</td>
                                    <td><strong>vaccination site pain</strong></td>
                                    <td>
                                        Sore arm at the injection site; Exhaustion; Achy body; Low-grade fever; This is a spontaneous report...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Sore arm at the injection site; Exhaustion; Achy body; Low-grade fever; This is a spontaneous report from a contactable consumer (patient). A 76-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL8982 and expiration date not provided), via an unspecified route of administration (left arm) first dose on 26Jan2021 14:30 at single dose for Covid-19 immunization administered at Hospital. The patient&#39;s medical history Have a stent in my heart, mild heart attack 2&#43; years ago, and Covid-19. The patient&#39;s concomitant medication included acetylsalicylic acid (BABY ASPIRIN) at 83 mg, metoprolol, and evolocumab (REPATHA). On 26Jan2021 21:30, the patient experienced Sore arm at the injection site, exhaustion, achy body, low-grade fever. The patient did not received treatment for the events. The reporter assessed the events as non-serious. The outcome of the events was recovering. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>76</td>
                                    <td>2021-02-28</td>
                                    <td><strong>redness, itchy skin</strong></td>
                                    <td>
                                        Patchy red skin on both thighs. Slightly itchy.; Patchy red skin on both thighs. Slightly itchy.; Th...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Patchy red skin on both thighs. Slightly itchy.; Patchy red skin on both thighs. Slightly itchy.; This is a spontaneous report from a contactable consumer. A 76-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot and expiry not reported), via an unspecified route of administration on 21Jan2021 at 09:45 at a single dose on left arm for COVID-19 immunisation. The patient&#39;s medical history and concomitant medications were not reported. The patient experienced patchy red skin on both thighs, slightly itchy on 21Jan2021. Therapeutic measures were taken as a result of both events (steroid cream). The outcome of the events was not recovered.  Information on the lot/batch number has been requested.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>76</td>
                                    <td>2021-02-28</td>
                                    <td><strong>vaccination site pain</strong></td>
                                    <td>
                                        Quite tired; He has a slight headache; he felt achy/Body aches and pains; Injection site pain; Had a...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Quite tired; He has a slight headache; he felt achy/Body aches and pains; Injection site pain; Had a fever 99.7F, 99.9 fever, later 101F; discomfort/slight injection site discomfort; This is a spontaneous report from a contactable consumer (patient). A 76-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, lot number EL9263, expiry date not reported), intramuscular on 26Jan2021 12:00 at a single dose in the left arm for COVID-19 immunization. Medical history included years ago he did have an issue with a lung disease when he went to (country name); he did have COVID 19 in Mar2020 and he recovered from that; high blood pressure; psoriatic arthritis diagnosed 30 years ago; and non-smoker. Family medical history included that they are all smokers in his family, and he is not. His sister died of pancreatic cancer and his mother died of oat cell lung cancer. Concomitant medications included valsartan (DIOVAN 160 mg) for high blood pressure at 160 mg, daily started 3.5 years ago to an unknown date; and patient was taking some health store vitamins. The patient previously took infliximab (REMICADE) on unspecified dates 5 years ago as Arthritis medication administered IV and apparently it lowered his immune system and he wound up in the hospital with a lung infection. He recovered completely. He does not have a lot or expiration. It was administered in the doctor&#39;s office and he does not go to that doctor anymore. It was reported that patient had no prior vaccinations (within 4 weeks).  He had second dose of Shingles vaccine and it was close to 4 weeks ago. Shingrix administered on upper left arm received it at an in-store clinic, and patient had slight injection site discomfort. No other vaccines administered on same date of the Pfizer suspect. Patient received the first dose of the Covid 19 vaccine on 26Jan2021 at noon, with just a bit of discomfort. He seemed to be fine except slight injection site discomfort, also reported as injection site discomfort on left upper arm, on 26Jan2021. Later that night (also reported as last night 26Jan2021 23:00) he felt achy, he had bad body aches and pain and still has it this morning. Injection site pain worsened last night and now it has improved. He woke up in the middle of the night, and had a fever 99.7 F, 99.9 fever and later it went as high as 101 F (26Jan2021). He took Advil and Tylenol. The body aches improved after he took 2 Tylenol when he took his temperature. He took temperature about 1.5 hour ago. He went into bed and waited and took it again about 1/2 hour ago and it went up to 101. He then took Tylenol and took his temperature again. This morning (27Jan2021) his temperature was now back/down to 99.3 F. He was still feeling aches but not as bad as before. He might still have a slight temperature now, but it has improved. He believed vaccination was given in the muscle because it was in the upper part of his arm where the skin is thinner. He had a slight headache and was quite tired (27Jan2021). Patient asked if there&#39;s anything he should do or be concerned about. He was scheduled for the second dose on 16Feb2021 and he heard that the second dose was stronger than the first one, that after the second dose there may be more side effect, and he wanted to know if this is true and wanted to know if he can get the second dose. Therapeutic measures were taken as a result of the events discomfort/slight injection site discomfort, he felt achy/body aches and pains, fever, and injection site pain. Patient had no ER or physician&#39;s office required. The events discomfort/slight injection site discomfort, he felt achy/body aches and pains, fever, and injection site pain were recovering. The outcome of the event tired and headache was unknown.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>76</td>
                                    <td>2021-03-07</td>
                                    <td><strong>vaccination site pain</strong></td>
                                    <td>
                                        No problem at first 9 days after injection I woke up with a very sore spot of the injection/his arm ...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                No problem at first 9 days after injection I woke up with a very sore spot of the injection/his arm is hurting, the same arm he received the injection in; his arm is hurting, states it is his left shoulder and arm, the same arm he received the injection in; his arm is hurting, states it is his left shoulder and arm, the same arm he received the injection in/could be a sign of an infection; This is a spontaneous report from a contactable consumer (patient). A 76-year-old male patient received his first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: El3247; expiration date: unknown) at vaccination age of 76-year-old via an unspecified route of administration in the left arm on 02Feb2021 12:00 at a single dose for covid-19 immunization. The patient&#39;s medical history concomitant medications were none. The patient has no allergies to medications, food, or other products. The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the COVID-19 vaccine in a public health clinic/veterans administration facility. The patient reported that there was no problem at first 9 days after injection. He woke up with a very sore spot on the injection on 11Feb2021. The event did not received treatment for the adverse event. The patient considered the event was non-serious. The patient has not been tested for COVID-19 since the vaccination. The patient further stated that got the Pfizer Covid vaccination on 02Feb2021, but he had no reaction and everything was fine. He mentioned that this morning (11Feb2021) which was 9 days later, his arm was hurting. He stated that it was his left shoulder and arm, the same arm he received the injection in which was given the injection by the employer. The patient wanted to know if it is normal to experience this type of reaction 9 days later. He was wondering if it could be a sign of an infection. The patient was encouraged to reach out to his healthcare provider. The outcome of the events was not recovered.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>76</td>
                                    <td>2021-03-15</td>
                                    <td><strong>itchy skin, vaccination site pain, injection site redness</strong></td>
                                    <td>
                                        Sore developed under the bandaid placed on injection site; there was a big red dot and it was itchy;...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Sore developed under the bandaid placed on injection site; there was a big red dot and it was itchy; there was a big red dot and it was itchy; Also both my arms are stiff and i have some pain.; This is a spontaneous report from a contactable consumer (patient). A 76-years-old male patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot #: El9263), via an unspecified route of administration on 28Jan2021 09:30 at single dose at Left arm for covid-19 immunization. Medical history included stents for my heart. Concomitant medication included metoprolol, acetylsalicylic acid (BABY ASPIRIN), furosemide and clopidogrel. The patient previously took gefalexin and levaquin and experienced drug hypersensitivity. On 29Jan2021 08:00, sore developed under the bandaid placed on injection site and the patient reported as, he received first dose on 28Jan2021, right afterwards the next morning I removed the band aid they had placed and there was a big red dot and it was itchy. Also both my arms are stiff and i have some pain. I got the injection on the Left arm but the Right arm feels the same. I spoke with my doctor he told me to put bacitracin on it for few days but it&#39;s still there. It&#39;s less itchy but the red dot is still there its 2-3 inches from the injection site and also said, I think I&#39;m going to skip the second dose. A red sore developed under the band aid that was applied to cover the injection site. It is under the right edge of the band aid. The area where the exact needle penetrated is healed. Both arms are sore at the top by where they meet the shoulder. Outcome of the events were not recovered.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>76</td>
                                    <td>2021-03-15</td>
                                    <td><strong>rash, redness</strong></td>
                                    <td>
                                        Very red face; Broke out in rash that eventually covered my whole body; This is a spontaneous report...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Very red face; Broke out in rash that eventually covered my whole body; This is a spontaneous report from a contactable consumer (patient). A 76-years-old male patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: El3248), via an unspecified route of administration from 29Jan2021 11:00 to an unspecified date at single dose for covid-19 immunization. Medical history included 2 knee replacement, diabetic, high blood pressure, anemic and allergies to penicillin. Concomitant medication included insulin, paracetamol (TYLENOL) and metformin. The patient previously took Benadryl and experienced drug hypersensitivity. The patient experienced very red face and broke out in rash that eventually covered my whole body on 29Jan2021 at 18:15. The outcome of the event was not recovered.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-01-04</td>
                                    <td><strong>vaccination site pain</strong></td>
                                    <td>
                                        vomited; nausea/ felt sick to his stomach; felt woozy; didn&#39;t feel well; right deltoid soreness; Thi...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                vomited; nausea/ felt sick to his stomach; felt woozy; didn&#39;t feel well; right deltoid soreness; This is a spontaneous report from a contactable physician (patient). A 77-years-old male patient received the first dose of BNT162B2 (Lot: EH9899), via an unspecified route of administration in deltoid right, on 24Dec2020 11:30 at single dose for COVID -19 immunization. Medical history included pulmonary embolism half a dozen years ago. He has had no problems with Deep Vein Thrombosis or pulmonary emboli since then, since half a dozen years. He has had a battery of lab tests 2 months ago, his blood glucose was high, it was 106 mg. The potassium was ok. He has had no issues with vaccines in the past. He had an antibody test last Jul2020 because he had bacterial lower urinary tract prostate infection. Concomitant medication included rivaroxaban (XARELTO) at 10 mg a day and cefalexin sodium (CEPHALEXIN) at 500 mg three times a day, well approximately 3, sometimes he forget a dose. The physician reported possible side effects of Covid vaccine. The physician received the vaccine on 24Dec2020 at 11:30 in the late morning and felt fine. He woke up on 25Dec2020 and at 2:30AM he was sick to his stomach and vomited and didn&#39;t feel well the rest of the day. Since then he had been okay, he had occasional nausea and vomiting. He clarified that on 24Dec2020, in the late evening, his appetite which was usual, was robust. Then on 25Dec2020 at 2:30 in the morning he vomited, and had no trouble since then. From what he read, nausea and vomiting are observed following the injection. On 24Dec2020 just before bed, he had a light supper, his appetite was robust, then unexpectedly he woke up sick to his stomach and went back to bed on 25Dec2020. He clarified that he had not vomited since the one episode on 25Dec2020. He also added that he has not been nauseous since then. Caller also added that he felt a little woozy on Holiday 25Dec2020, it only lasted up until the evening of 25Dec2020. He had the 1 episode vomiting on 25Dec2020 and felt woozy until late evening of 25Dec2020. His right deltoid where he received the vaccine was a little bit sore on 24Dec2020, and he was still having a little bit of soreness, it is slight, not very tender, he is unable to do usual morning exercises with out noticing the discomfort, the exercise he is doing is chin ups, the soreness is not intense and it never was. The lab test in 2020 included Height: under 5 feet 5 inches. Weight: about 165lbs or 167lbs. He had no positive test for COVID prior to the vaccine. All the tests were negative. The 1st one was nasopharyngeal, and all the next ones after were nasal swabs. He thought they are all reverse transcriptase tests. The last time he had a COVID test they did a nasal swab, it was this morning, and before that was last Monday or Tuesday, but he thought more so Monday. He had one PCR test. The outcome of the events vomited, nausea and felt woozy was recovered on 25Dec2020. The outcome of the event right deltoid soreness was recovering. The outcome of the other event was unknown. The 2nd dose for Covid vaccine was schedule for 14Jan2021.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-01-06</td>
                                    <td><strong>injection site pain</strong></td>
                                    <td>
                                        THE NIGHT OF VACC DAY, C/O SEVERE INJ ARM PAIN.  THE FOLLOWING DAY, HE BEGAN DISPLAYING VERBAL AGGRE...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                THE NIGHT OF VACC DAY, C/O SEVERE INJ ARM PAIN.  THE FOLLOWING DAY, HE BEGAN DISPLAYING VERBAL AGGRESSION AND OUTBURST TOWARDS STAFF WHICH IS OUT OF NORMAL FOR HIM, INCREASED DIFF REMEMBERING SHORT TERM, C/O DIZZINESS AND SEVERE HEADACHE RATED 10/10 ON PAIN SCALE NOT RELIEVED WITH SEVERAL DOSES OF PAIN MEDS AND RANDOM DIZZINESS
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-01-06</td>
                                    <td><strong>injection site pain</strong></td>
                                    <td>
                                        THE NIGHT OF VACCINATION DAY, RESIDENT BEGAN C/O SEVERE PAIN IN THE INJECTION ARM.  THE DAY AFTER TH...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                THE NIGHT OF VACCINATION DAY, RESIDENT BEGAN C/O SEVERE PAIN IN THE INJECTION ARM.  THE DAY AFTER THE VACCINE,  HE BEGAN HAVING MOOD ISSUES, VERBAL AGGRESSION/OUTBURSTS (ABNORMAL FOR THIS RESIDENT), DIZZINESS AND A SEVERE HEADACHE HE RATED AT 10/10 PER PAIN SCALE THAT DID NOT RESOLVE WITH SEVERAL DOSES OF PAIN MEDS.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-01-15</td>
                                    <td><strong>rash</strong></td>
                                    <td>
                                        Red and black spots on inside upper left arm. Soreness and a little pain.
                                        
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-01-24</td>
                                    <td><strong>vaccination site swelling</strong></td>
                                    <td>
                                        sore arm/soreness in the arm; a little swelling, slight swelling/there was a little swelling where i...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                sore arm/soreness in the arm; a little swelling, slight swelling/there was a little swelling where it was injected; This is a spontaneous report from a contactable consumer (patient). This reporter reported similar events for two patients. This is 1st of 2 reports.   A 77-year-old male patient received first dose of bnt162b2 (PFIZER- BIONTECH COVID-19 VACCINE) at left arm, via an unspecified route of administration on 11Jan2021 12:00 at single dose for covid-19 immunisation. Medical history included ongoing diabetes mellitus. Family Medical History was None. The patient previously had pneumonia shot that he had a pretty bad reaction to one time. It was hard to explain, he had sloughing to the skin on the left arm. Under the left arm was hanging down about 3-4 inches. There was some fluid of some sort. He went to the clinic and they gave him something and it went away and he was told not to get another one. It was about 8-9 years ago. The patient&#39;s concomitant medications were not reported. The patient experienced sore arm and a little swelling, slight swelling on 11Jan2021. The patient noticed the soreness in the arm about 2-3 hours after getting the shot, but it was getting better, but there was a little swelling where it was injected. There was slight swelling, but not much. The outcome of event &#34;sore arm/soreness in the arm&#34; was unknown; of event &#34;a little swelling, slight swelling/there was a little swelling where it was injected&#34; was not recovered.   Lot/batch number has been requested.; Sender&#39;s Comments: Linked Report(s) : US-PFIZER INC-2021026404 same reporter/product, different patient.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-02-04</td>
                                    <td><strong>skin spots, rash</strong></td>
                                    <td>
                                        Thrombocytopenia, SkinRash, Rash &amp; ElevatedBunSCr Narrative: Petichial rash. Patient had IV contrast...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Thrombocytopenia, SkinRash, Rash &amp; ElevatedBunSCr Narrative: Petichial rash. Patient had IV contrast dye 1/19 no reaction. Patient on Apixiban for a. fib.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-02-16</td>
                                    <td><strong>bruising</strong></td>
                                    <td>
                                        Fall 2/4 hospital admission 2/7/21 with death on 2/8/2021.  Patient continued to decline on Bipap he...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Fall 2/4 hospital admission 2/7/21 with death on 2/8/2021.  Patient continued to decline on Bipap he was a DNR/DNI and family decided on comfort measures and he expired 2/8/2021.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-02-17</td>
                                    <td><strong>vaccination site pain</strong></td>
                                    <td>
                                        Hypothermia/A temperature of 93.7 orally/temperature was 92.7/went down to 93.2 degrees; Chills; The...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Hypothermia/A temperature of 93.7 orally/temperature was 92.7/went down to 93.2 degrees; Chills; The arm he received the injection in was tender however progressed to mild to moderately painful/arm was suddenly painful; Shaking; Injection site tenderness; This is a spontaneous report from a contactable physician (patient). A 77-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot: EL9262, expiry: unknown), via an unspecified route of administration in the left arm on 26Jan2021 15:30 at a single dose for protection from the virus at the Physician Office. Medical history included type 2 diabetes mellitus from 2011 and ongoing. The patient also thought he had a Covid respiratory infection in Feb2020. He had a prolonged moderate to severe respiratory infection. He thought at first that he had the flu, but he had a flu shot. He thinks he had Covid. He had antibody studies in May2020 (last spring) that were negative. The patient has no concomitant medications. The patient previously had influenza vaccine (flu shot). The patient reported hypothermia after getting the first dose of the Pfizer Covid 19 vaccine. On the same day of vaccination (26Jan2021), he had injection site tenderness. The next day, (27Jan2021), his arm was suddenly painful; he began to have chills 29 hours after receiving the vaccine (27Jan2021) and was shaking. He also had a temperature of 93.7 orally, confirmed with two different digital thermometers. He took his temperature with a new electronic thermometer that he purchased at a pharmacy. His temperature was 92.7 on 27Jan2021. He repeated it with another electronic thermometer. The first evening (27Jan2021), his temperature went to 96.5 to 98 degrees. Then it went down to 93.2 degrees. He covered up with blankets and his temperature increased and the chills stopped. He stated that this was hypothermia. He had low temperatures the following day (28Jan2021) as well, his temperature was 93-94 degrees. His temperature was 93.7 degrees. Other times he checked his temperature and it was 96.5 degrees. When his temperature was low the first time, it only lasted for about three hours. The second time it happened he went to bed and covered up. It lasted for an hour or two. He noticed it again two days ago. The patient also stated the arm he received the injection in was tender however progressed to mild to moderately painful when he experienced the chills and low temperatures. The arm tenderness after getting the vaccine was very mild. He noticed it when he rolled over on his arm. He took some Tylenol for it. His son is an internist. He said the hypothermia was medically significant. His son also said hypothermia is equivalent to a fever in the elderly. The patient wanted to know if there have been any reports of hypothermia after the administration of the vaccine. He has concerns about this occurring after the second dose. He is scheduled to receive the second dose on 15Feb2021 or 16Feb2021. The outcome of the event hypothermia was recovered on 30Jan2021 and pain in arm recovered on 27Jan2021. The outcome of the other events was unknown. The events hypothermia, arm pain and injections site tenderness were assessed as related to BNT16B2.; Sender&#39;s Comments: The Company cannot completely exclude the possible causality between the reported hypothermia and the administration of the COVID-19 vaccine, BNT162B2, based on the reasonable temporal association and lacking alternative explanations.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-02-21</td>
                                    <td><strong>injection site reaction</strong></td>
                                    <td>
                                        2-3 weeks after COVID vaccination, patient presented to hospital with anemia and thrombocytopenia an...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                2-3 weeks after COVID vaccination, patient presented to hospital with anemia and thrombocytopenia and intracranial hemorrhage.  L axillary mass (same side as Pfizer vaccine admin site) found on exam. Bone marrow biopsy demonstrated Burkitt&#39;s Lymphoma. He is undergoing treatment at hospital
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-02-22</td>
                                    <td><strong>injection site pain</strong></td>
                                    <td>
                                        Injection site pain; tiredness; headache; chills; fever; nausea; feeling unwell
                                        
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-02-22</td>
                                    <td><strong>blister, rash</strong></td>
                                    <td>
                                        Pfizer COVID vaccine  first shot Jan. 16 2021   SECOND SHOT 2/6/21          first shot developed ras...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Pfizer COVID vaccine  first shot Jan. 16 2021   SECOND SHOT 2/6/21          first shot developed rash on left upper leg and blisters on lt foot. was almost gone then after second shot sunday morning woke up with rash both upper legs, bach and many blisters on feet, has been same but more rash on both legs and body , many blisters on both feet could  hardly walk sunday and monday after second shot
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-02-23</td>
                                    <td><strong>injection site pain</strong></td>
                                    <td>
                                        1. Pain at site of injection started about 6 hours post second vaccine injection (7-8 on a 0-10 scal...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                1. Pain at site of injection started about 6 hours post second vaccine injection (7-8 on a 0-10 scale) that lasted for almost 48 hours, most intense during the day following injection. No treatment for that. 2. Significant fatigue on the morning  14 hours following the injection (could have started during the night) . Difficult to maintain balance. Just rested the whole day. Unable to exercise on stationary bike. 3. Low grade fever (just under 99 F; base line for me has been 97.6 F) in the evening following injection, gone next morning. No treatment.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-02-28</td>
                                    <td><strong>rash</strong></td>
                                    <td>
                                        Rash- left calf, ankle to knee; Received BNT162B2 with medical history of Psoriatic arthritis; Recei...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Rash- left calf, ankle to knee; Received BNT162B2 with medical history of Psoriatic arthritis; Received BNT162B2 with medical history of Psoriatic arthritis; This is a spontaneous report from a contactable consumer (patient).  A 77-year-old male patient received his first dose of bnt162b2 (BNT162B2 also reported as COVID 19 brand Pfizer, lot EJ1686), via an unspecified route of administration in the left arm on 20Jan2021 10:15 at SINGLE DOSE for Covid-19 immunisation. Medical history included type 2 Diabetic, Psoriatic arthritis and had heart disorder, allergic to sulfa drugs. He did not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included warfarin, sitagliptin phosphate, aspirin (acetylsalicylic acid). The patient experienced rash in the left calf, ankle to knee on 22Jan2021 08:00 (no treatment). The outcome of event was not recovered.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-02-28</td>
                                    <td><strong>itchy skin</strong></td>
                                    <td>
                                        itched everywhere ears, scalp legs and arms.; headache; tired; itchy nose; This is a spontaneous rep...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                itched everywhere ears, scalp legs and arms.; headache; tired; itchy nose; This is a spontaneous report from a contactable consumer (patient) A male patient of an unspecified age received BNT162B2 (Solution for injection, Lot/Batch number was not reported) via an unspecified route of administration on 21Jan2021 at single dose for covid-19 immunisation. The patient&#39;s medical history and concomitant medications was not reported. The patient received the first vaccine on 21Jan2021. He had a headache, tired and itchy nose. He took a benadryl and it went away. On 25Jan2021 that he itched everywhere ears, scalp legs and arms. The symptoms went away 30 minutes after Benadryl. The patient was not getting any better and maybe a little worse. The outcome of the events was recovered on an unspecified date of 2021.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-03-02</td>
                                    <td><strong>itchy rash, skin spots, rash</strong></td>
                                    <td>
                                        2 days after 2nd dose of Pfizer vaccine pt developed stuffy nose, SOB, but no cough, fever, or chill...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                2 days after 2nd dose of Pfizer vaccine pt developed stuffy nose, SOB, but no cough, fever, or chills, then developed an itchy rash on Rt foot that spread to arms and legs resulting in a peticheal rash/lesions on dorsum of feet, shins, thigh, mid abdomen, medial arm and back.   Dermatology consult felt due to allergic purpura, and vasculitis possible but less likely.  Platlet count in the normal range.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-03-11</td>
                                    <td><strong>itchy skin, hives</strong></td>
                                    <td>
                                        After  Does 1, I broke out into hives, I was given prednisone and the swelling and itching did go do...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                After  Does 1, I broke out into hives, I was given prednisone and the swelling and itching did go down. After dose 2, The hives returned and I developed plaque psoriasis all over my body in perhaps 20 locations. I was given prednisone again, the itching stopped  but The psoriasis remains and is getting worse. As a note, I have had psoriasis for most of my life on my hands and feet, but after this experience I have psoriasis all over my body.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-03-14</td>
                                    <td><strong>vaccination site pain</strong></td>
                                    <td>
                                        low temperature (96.5); Chills; slight tremors; soreness at injection site; This is a spontaneous re...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                low temperature (96.5); Chills; slight tremors; soreness at injection site; This is a spontaneous report from a non-contactable consumer (patient). A 77-years-old male patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3247), via an unspecified route of administration on 10Feb2021 08:15 at age of 77-years-old at arm left at single dose for COVID-19 immunisation. Medical history included bladder cancer, high blood pressure and no known allergies. Concomitant medication included allopurinol, amlodipine, valsartan, indapamide, atorvastatin (LIPITOR), pregabalin (LYRICA), metformin hydrochloride (MEDFORMIN), metoprolol succinate (TOPROL) and vitamin supplements. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The historical vaccine included the 1st dose of BNT162B2 on 18Jan2021 at age of 77-years-old for COVID-19 immunisation. The patient experienced chills, low temperature (96.5) and slight tremors, soreness at injection site on 10Feb2021 06:00 (as reported). No treatment was received for the adverse events. The events outcome was recovered on an unspecified date in Feb2021. No COVID prior vaccination, since the vaccination the patient hadn&#39;t been tested for COVID-19.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>77</td>
                                    <td>2021-03-17</td>
                                    <td><strong>redness, cellulitis</strong></td>
                                    <td>
                                        Progressive Left arm pain/shoulder soreness that began 5 days prior to hospital presentation. Seen i...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Progressive Left arm pain/shoulder soreness that began 5 days prior to hospital presentation. Seen in ambulatory clinic 7 days prior to presentation, given ibuprofen and percocet without relief. New swelling and erythema brought pt to hospital. Around time of vaccination, the pt was using triamcinolone for left forearm rash (described as small, more-spotty and resolved quickly). MRI revealed an abscess (10 x 6.8 x 1 cm) deep to the deltoid muscle and along the lateral aspect of the left proximal humerus. He also has another abscess within the posterior deltoid muscle (3.1 x 2.1 x 2.8 cm). There is surrounding myositis, fasciitis and cellulitis.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>78</td>
                                    <td>2021-01-14</td>
                                    <td><strong>rash, itchy skin</strong></td>
                                    <td>
                                        Rash lower back, itching on back, leg, lower stomach.; Rash lower back, itching on back, leg, lower ...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Rash lower back, itching on back, leg, lower stomach.; Rash lower back, itching on back, leg, lower stomach.; This is a spontaneous report from a contactable consumer (patient). A 78-year-old male patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246) solution for injection, via an unspecified route of administration on left arm on 07Jan2021 17:15 at a single dose for COVID-19 immunization. Medical history included hypertension, kidney disease stage 3, UTI (urinary tract infection), enlarged prostate, and known allergy to penicillin. Concomitant medication included amlodipine, benazepril, tamsulosin, ergocalciferol (VIT D), and unspecified multivitamin. The patient experienced rash lower back, itching on back, leg, lower stomach on 09Jan2021 at 2pm. No treatment received. The events were reported as non-serious. The patient was not diagnosed with Covid-19 prior to vaccination. The patient has not been tested for Covid-19 since the vaccination. Outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>78</td>
                                    <td>2021-01-19</td>
                                    <td><strong>injection site swelling</strong></td>
                                    <td>
                                        Site: Swelling at Injection Site-Mild, Systemic: Hematoma (2.5 cm) at injection site-Mild
                                        
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>78</td>
                                    <td>2021-01-24</td>
                                    <td><strong>redness</strong></td>
                                    <td>
                                        hypoxemia, urinary retention Narrative: Transferred from facility to ED with 1 day of fevers, hypote...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                hypoxemia, urinary retention Narrative: Transferred from facility to ED with 1 day of fevers, hypotension, and c/f new oxygen requirement and admitted to acute care ward on 1/14/21. Tachycardia resolved w/ fluids. Patient was ruled out for PE and infectious workup negative. Fevers, hypoxia resolved overnight. Medicine Team felt symptoms were side effects from COVID vaccine (2nd dose received 1/13). He was treated for possible cellulitis at L shin wound (warm and tender to touch with mild erythema, without fluctuation) with 14-day cephalexin course, however cellulitis not deemed severe and unlikely contributing. Regarding urinary retention, the Discharge Summary stated, &#34;Urinary retention seemed new in the last day. Pt on condom cath during admission, urinating well.&#34; Discharged 1/15/21 and returned to facility.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>78</td>
                                    <td>2021-01-25</td>
                                    <td><strong>vaccination site pain</strong></td>
                                    <td>
                                        headache; chills; fever; muscle soreness; injection site soreness; This is a spontaneous report from...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                headache; chills; fever; muscle soreness; injection site soreness; This is a spontaneous report from a non-contactable consumer (wife). A 78-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 14Jan2021 at single dose for COVID-19 immunization.  Medical history and concomitant medications were not reported. On 14Jan2021 19:00, the patient had headache, chills, fever, muscle soreness and injection site soreness. Outcome was unknown. Information on batch number has been requested.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>78</td>
                                    <td>2021-01-28</td>
                                    <td><strong>vaccination site pain</strong></td>
                                    <td>
                                        injection site pain to right arm; Chills; Headache; light fever; This is a spontaneous report from a...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                injection site pain to right arm; Chills; Headache; light fever; This is a spontaneous report from a contactable consumer. A 78-year-old male patient received his first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number ELL742) on his right arm, via an unspecified route of administration on 14Jan2021 07:00 at a single dose for covid-19 immunization. The patient&#39;s medical history and concomitant medications were not reported. It was reported that the patient got injection site pain to right arm, chills, headache and a light fever; all on 14Jan2021 19:00. It was also stated that the injection site pain was severe and is now less. Also reported that the patient recovered from the chills during the night completely. The patient took a couple of aspirin last night and will take some more this morning as treatment. The outcome of the event chills was recovered on 14Jan2021, not recovered for event light fever while recovering for the remaining events.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>78</td>
                                    <td>2021-02-25</td>
                                    <td><strong>rash</strong></td>
                                    <td>
                                        Dizziness; Hypoglycemia; Hypotension; Generalized rash; This is a spontaneous report from a non-cont...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Dizziness; Hypoglycemia; Hypotension; Generalized rash; This is a spontaneous report from a non-contactable healthcare professional. A 78-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EN5318; dose 1) intramuscularly on 25Jan2021 (at the age of 78-years-old) as a single dose in the right arm for COVID-19 immunization. Medical history and concomitant medications were not reported. On 25Jan2021 during the 15 minute waiting period after the vaccine, the patient experienced dizziness. He denied difficulty breathing and swallowing. A differential diagnosis of systemic reaction (hypoglycemia, hypotension, generalized rash) was provided. The patient was given unspecified treatment and follow-up response was good. The patient denied dizziness when standing up and walking to leave the medical evaluation bay and clinical outcome of dizziness was completely resolved prior to discharge.   No follow-up attempts are possible. No further information is expected.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>78</td>
                                    <td>2021-02-28</td>
                                    <td><strong>vaccination site itchiness</strong></td>
                                    <td>
                                        Experiencing extreme itching on site of vaccine.; This is a spontaneous report from a contactable co...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Experiencing extreme itching on site of vaccine.; This is a spontaneous report from a contactable consumer reported for himself.  A 78-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), from lot # EN6201, via unknown route at left arm on 18Feb2021 at 12:15 (at the age of 78-year-old) at single dose for covid-19 immunization. The patient received the first dose of the same vaccine on 28Jan2021 at 12:15 AM at the left arm from lot # EL3248. The patient experienced extreme itching on site of vaccine. The outcome of the event was not recovered. No COVID prior vaccination. Patient has not been tested for COVID-19. Adverse event result in hospitalization, Life threatening illness, Disability or permanent damage, Congenital anomaly.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>78</td>
                                    <td>2021-03-02</td>
                                    <td><strong>vaccination site pain</strong></td>
                                    <td>
                                        Mild soreness at the injection site; This is a spontaneous report from a non-contactable consumer (p...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Mild soreness at the injection site; This is a spontaneous report from a non-contactable consumer (patient). A 78-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EM9809), via an unspecified route of administration on left arm on 08Feb2021 at the age of 78 years old at a single dose for COVID-19 immunisation at Doctor&#39;s office/urgent care. Medical history included high cholesterol. Allergies to medications, food, or other products was none. Concomitant medications included unspecified medications. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other medications within 2 weeks of vaccination. Historical vaccination included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) received at the age of 78 years old on an unknown date for COVID-19 immunization. On 08Feb2021, the patient experienced mild soreness at the injection site. The patient assessed the event as non-serious. It was unknown if the treatment was received in response to the adverse event. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. The patient was recovering from the event.  No follow-up attempts are possible. No further information is expected.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>78</td>
                                    <td>2021-03-02</td>
                                    <td><strong>vaccination site pain</strong></td>
                                    <td>
                                        Right arm was barely sore where injection administered; This is a spontaneous report from a contacta...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Right arm was barely sore where injection administered; This is a spontaneous report from a contactable consumer (patient).  A 78-year-old male patient received first dose of BNT162B2 (Lot number: EL0142), via an unspecified route of administration on 11Jan2021 17:05 at single dose in the right arm for vaccination. Medical history included eye vitamin/To maintain good eye health, eye disorder, Heart supplement, heart disorder and he had his last annual physical with Pneumocystis pneumonia (PCP) in Oct2020. He had his flu shot in Sep2020. Concomitant medication included ramipril taken for probably at least 15 years, started in his 60s; atorvastatin taken for probably at least 15 years, started in his 60s. He believes this is the generic product for Pfizer Lipitor; acetylsalicylic acid (ASPIRIN CHILDREN) taken for probably at least 15 years, started in his 60s; ascorbic acid, tocopheryl acetate, xantofyl, zeaxanthin, zinc (AREDS) (also reported as &#34;Advanced Retinol Eye Study Disease&#34;) for eye vitamin/To maintain good eye health; bioflavonoids nos, lecithin, quercetin, ubidecarenone (CO-Q-10 PLUS) taken for probably at least 15 years, started in his 60s for Heart supplement; and unspecified multivitamin taken daily and probably taken all his life, all ongoing. This patient reported he was administered his first dose of Pfizer COVID-19 vaccine on 11Jan2021. There were no side effects; his right arm was barely sore where injection administered on 11Jan2021. Onset probably about 19:05-20:05 and he had recovered completely by the next morning when he woke. He had no discomfort during the night, no pain or throbbing, he felt very normal the next morning. He clarified that he has no medical conditions, no flu or illnesses of any other kind. He had his last annual physical with PCP in Oct2020; he has a twice yearly check-up with the Cardiologist that will be coming up soon. Stated that today is the 21st day and he is scheduled to get his second dose at 3:00pm. He asked how the incremental immunity builds up percentage wise after getting the first and second dose of Pfizer COVID-19 vaccine. He asked if there is any restriction or limitation on taking products like Tylenol, Advil or Aspirin before getting the Pfizer COVID-19 Vaccine; and if those products are ok to use to potentially treat side effects from the Pfizer COVID-19 Vaccine such as if patient has sore arm or something; and how soon after the second dose side effects can kick in-he believes the briefing documents he was given for the Pfizer COVID-19 Vaccine said 2-14 days. He asked this particularly because he has an hour drive home after this second dose and wanted to know what to anticipate before attempting to drive home. His wife thought someone told her not to take any Tylenol, Advil or Aspirin before getting the Pfizer COVID-19 Vaccine which they had not heard of elsewhere, and saw no mention of that in the briefing documents given for the Pfizer COVID-19 Vaccine. The with outcome of the event was recovered on 12Jan2021.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>79</td>
                                    <td>2021-01-12</td>
                                    <td><strong>shingles</strong></td>
                                    <td>
                                        shingles left chest   painful   maculopapular     labs with elevated igg and igm vzv    still painfu...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                shingles left chest   painful   maculopapular     labs with elevated igg and igm vzv    still painful   lesions still present  no crusting or weeping   no past hx of shingles vaccine
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>79</td>
                                    <td>2021-01-13</td>
                                    <td><strong>rash, itchy rash</strong></td>
                                    <td>
                                        Rash is itching; rash under his arms from armpit to elbows underneath and on his sides below his bel...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Rash is itching; rash under his arms from armpit to elbows underneath and on his sides below his belly button and in the groin area and on his buttocks; This is a spontaneous report from a contactable consumer (patient&#39;s wife). A 79-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at the right arm on 02Jan2021 00:45 at a single dose for COVID-19 immunization. Medical history included hard of hearing, surgery to remove the cancer, cancer broke his arm and he had a reverse shoulder replacement (medical conditions predating treatment with Pfizer COVID 19 vaccination); kidney failure that is better, muscle (disorder), blood pressure (abnormal), anxiety and radiation. The patient was previously given oxycodone, Ativan, and Xanax to take as needed after his surgery, but he has not taken them since Oct2020. Concomitant medication included sertraline hydrochloride (ZOLOFT) for anxiety, amlodipine for blood pressure, metoprolol for blood pressure, tamsulosin hydrochloride (FLOMAX) from Sep2020 for kidney, carisoprodol (SOMA) from 22Oct2020 for muscle relaxant, ferrous sulfate, docusate sodium (STOOL SOFTENER), aspirin [acetylsalicylic acid] (ASPIRIN [ACETYLSALICYLIC ACID]) all were ongoing and other unspecified products. The reporter stated that she and her husband got the vaccine on 02Jan2021 and the husband has developed a rash under his arm from his arm pit to elbow underneath, on his sides, below his belly button and in the groin area and on the buttocks. Rash was itching on 06Jan2021. She wanted to know could the COVID 19 vaccine cause this 4 days later. The patient noticed the itchy rash four days later on Wednesday afternoon 06Jan2021. He took Benadryl 25mg tablet by mouth that night before bed and then in the morning and put over the counter itch relief cream on it so in the night around 0200AM not too long after taking the Benadryl, the rash went away, pretty much gone. Today it seems to have come back and now it was worse because he has it on his buttocks. He didn&#39;t have it there at first. Mentioned that the patient also took a cool shower before going to bed. Wife mentioned that she just looked the rash right now and it was improved. Asking should he continue taking his relief or stop and let the doctor look at it? Advised caller to consult HCP. He is planning to get the next vaccine 23Jan2021. There was no history of all previous immunization with the Pfizer vaccine considered as suspect. No additional vaccines administered on same date of the Pfizer suspect. The events did not require a visit to physician office and ER. No prior vaccinations (within 4 weeks). No relevant family medical history. No relevant tests done. Outcome of the events was recovering.   Information on the Lot/Batch number has been requested.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>79</td>
                                    <td>2021-01-15</td>
                                    <td><strong>redness</strong></td>
                                    <td>
                                        Injection received in left arm (shoulder) - a sore has developed near his arm pit about the size of ...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Injection received in left arm (shoulder) - a sore has developed near his arm pit about the size of a dime.  It has a scab and is red.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>79</td>
                                    <td>2021-01-26</td>
                                    <td><strong>itchy skin, rash</strong></td>
                                    <td>
                                        Rash starting on the right side of the face, spreading onto the trunk and then onto the extremities....
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Rash starting on the right side of the face, spreading onto the trunk and then onto the extremities.  Rash is confluent on the face, less intense in other areas, not very itchy. Feels well otherwise.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>79</td>
                                    <td>2021-02-15</td>
                                    <td><strong>rash, itchy skin</strong></td>
                                    <td>
                                        REPORT GIVEN BY HIS WIFE.  DAY ONE: ITCHING IN ODD AREAS OF BODY (UNDER ARMS AND BACKSIDE). NEXT DAY...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                REPORT GIVEN BY HIS WIFE.  DAY ONE: ITCHING IN ODD AREAS OF BODY (UNDER ARMS AND BACKSIDE). NEXT DAY FEELING TIRED. FRIDAY HE DID FEEL WELL AND O2 LEVEL 91% - 88%  THEN A RASH WAS NOTED FROM NECK DOWN TO LEGS. WIFE TOOK HIM TO THE  HOSPITAL SATURDAY MORNING. IN ER FOR ALLERGICE REACTION, BUT THEN TOOK A TURN FOR THE WORSE AND WAS PLACED ON BI PAP MACHINE FOR ABOUT 5 HOURS. DISCHARGED AFTER 5 DAYS IN HOSPITAL. ALLERGIST CALLED I N TO CONSULT-
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>79</td>
                                    <td>2021-02-23</td>
                                    <td><strong>rash</strong></td>
                                    <td>
                                        rash worsened; compromised immune system with the Multiple Myeloma/ getting the COVID-19 Vaccine; co...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                rash worsened; compromised immune system with the Multiple Myeloma/ getting the COVID-19 Vaccine; compromised immune system with the Multiple Myeloma/ getting the COVID-19 Vaccine; This is a spontaneous report from a contactable nurse for her husband. A 79-year-old male patient received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9261), via an unspecified route of administration at left arm on 26Jan2021 06:00 at single dose for covid-19 immunisation. Medical history included plasma cell myeloma from Oct2018, a compromised immune system with the Multiple Myeloma, rash from Dec2020 and ongoing. The patient had a diagnosis of multiple myeloma and had developed a slight rash on his left arm to lenalidomide (REVLIMID) before receiving the COVID vaccine, Benadryl was taken and after 3 days, it was gone.  It was only on his upper arms. She said a rash was a known side effect of the lenalidomide. The nurse giving his vaccine shot noticed his slight rash on his left arm. Concomitant medication included lenalidomide (REVLIMID) for 2.5 years for multiple myeloma in remission. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The past drug included bortezomib (VELCADE), the patient was administered a chemo agent (bortezomib) at the oncology center every 2 weeks and the oncology center held off giving his chemo shot 2 weeks before he received his first COVID-19 Vaccine on 26Jan2021. The reporter said her husband would not restart the chemo shot until he sees his oncologist again. She clarified her husband has now been off the bortezomib for a month, as of 01Feb2021. The patient experienced rash worsened on 28Jan2021. By 28Jan2021 the rash had spread to his trunk and by 29Jan2021 to his back. She clarified his rash was a dry rash, with no blisters or oozing. Her first thought was to get an ointment or a spray. He has now been given prednisone instead of a dose pack and the rash was gone/ the rash cleared up almost immediately and will stop lenalidomide for a couple weeks and continue the round of prednisone. The doctor could alter his therapy as needed. On 04Feb2021, the rash was gone but her husband&#39;s doctor wants him to finish his prescribed course of Prednisone. She clarified the Prednisone (manufacturer: Actavis) 40 mg was started on 01Feb2021, the rash started fading fast. By the next day (Tuesday, 02Feb2021) the rash was really fading, and now (04Feb2021) the rash was totally not there. The doctor told her husband to take one Benadryl, and to continue taking the Benadryl if his rash itches. She said her husband&#39;s latest blood work didn&#39;t indicate anything.  She said her husband&#39;s labs were always off, but were normal for having Multiple Myeloma. Both doctors want to keep her husband off of the lenalidomide. Reporter seriousness was reported as medically significant . The patient was treated for Multiple Myeloma for the past 2-1/2 years. He had been doing well, and his cancer doctors approved of him getting the COVID-19 Vaccine. The oncologist wanted her to call Pfizer to see if she can find anything about the COVID-19 Vaccine and how it pertains to the lenalidomide and her husband&#39;s Multiple Myeloma. She said her husband was almost 80 years old and very active. She said her husband had been in remission Multiple Myeloma for a year and his blood work was fine. By the time her husband starts taking lenalidomide again, he would be off of lenalidomide for almost 4 weeks. She said her husband&#39;s oncologist said he was going to cut back her husband&#39;s lenalidomide milligram dose and change his lenalidomide frequency to every other day when he resumes the lenalidomide. The reporter checked her husband&#39;s blood pressure (130/76) on 29Jan2021, after his rash worsened. She saidnot require a visit to emergency room or physician office. The rash event outcome  his pulse was fine, and she tested his blood sugar and it was fine. She said he had no temperature, clarifying his temperature was 97.6. The event did was recovering. The drug result was reported as unrelated. The reporter and her husband&#39;s doctors don&#39;t think his rash has anything to do with the COVID-19 Vaccine. The patient asked if Pfizer can point her in any direction with regard to her husband&#39;s situation. She said she read the COVID-19 Vaccine is a dead virus, but wants to know if her husband should be cautious in getting the second COVID-19 Vaccine dose. She said her husband&#39;s doctors know that the rash was not precipitated by the COVID-19 Vaccine, but his rash did get worse after he got the first COVID-19 Vaccine dose. His second dose was due 16Feb2021. The reporter was wondering if she should delay the second dose of the vaccine, the vaccine would make the rash worse.; Sender&#39;s Comments: Based on the information currently provided, the rash worsened after 2 days following the vaccine use thus a contributory role of BNT162B2 might not be fully excluded towards the event onset.  Severe allergic reaction is the known risk for the product and Rash faded soon under Prednisone.  The underlying predisposing condition of allergies to multiple materials may put the patient at high risk of anaphylactic reactions. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>79</td>
                                    <td>2021-03-02</td>
                                    <td><strong>itchy skin, rash, hives</strong></td>
                                    <td>
                                        a little bit of itching; kind of hives; uncomfortable at times, at his feet, and ankles; he has rash...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                a little bit of itching; kind of hives; uncomfortable at times, at his feet, and ankles; he has rashes; terrible skin; This is a spontaneous report from a contactable consumer (reporting for himself). A 79-year-old male patient received his first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248, expiration date: unknown), via an unspecified route of administration from 09Jan2021 to 09Jan2021 at single dose for COVID-19 immunization. The patient&#39;s medical history Ablation surgery. The patient&#39;s concomitant medications were not reported. On an unspecified date, the patient had a little bit of itching, kind of hives, he did not break out, he was uncomfortable at times, at his feet, and ankles. The patient has rashes, and terrible skin. The outcome of the events was unknown.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>79</td>
                                    <td>2021-03-02</td>
                                    <td><strong>vaccination site pain</strong></td>
                                    <td>
                                        not been feeling well at all; Injection site pain; This is a spontaneous report from a contactable c...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                not been feeling well at all; Injection site pain; This is a spontaneous report from a contactable consumer (patient). A 79-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, lot number: EL9262, expiry date unknown), via an unspecified route of administration at the left arm on 29Jan2021 13:15 at a single dose for COVID-19 immunization. The patient&#39;s medical history and concomitant medications were not reported. The patient reported  that he had an injection site pain on 29Jan2021. It was still sore after 3 days and the day afterwards he was not been feeling well at all on 30Jan2021. He was not sure if it has any effect on it, but had a pacemaker put on the right side of his chest in a week before getting the shot so he was not sure if that could affect how he was feeling. The outcome of the event &#39;injection site pain&#39; was not recovered and the outcome of the event &#39;not been feeling well at all&#39; was recovering. The vaccination facility type was hospital. The vaccine was not administered at the military facility.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>79</td>
                                    <td>2021-03-02</td>
                                    <td><strong>hives, rash</strong></td>
                                    <td>
                                        welts and rash on back and chest with second shot; welts and rash on back and chest with second shot...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                welts and rash on back and chest with second shot; welts and rash on back and chest with second shot; This is a spontaneous report from a contactable consumer (patient). A 79-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL9265, expiration date: May2021), via an unspecified route of administration on 29Jan2021 at single dose for COVID-19 immunisation. Medical history included ablation surgery from an unknown date about two to three months ago. The patient&#39;s concomitant medications include an unspecified blood pressure medicine. The patient previously received the first dose of BNT162B2 (lot number: EL3248, expiration date: Apr2021) on 09Jan2021 for COVID-19 immunization and experienced had a little bit of itching, kind of hives, uncomfortable at times, has rashes, terrible skin. On 30Jan2021, Saturday evening, it was reported that the patient experienced welts and rash on back and chest with second shot and were probably worse on Sunday, he doesn&#39;t know if it is better today or not, perhaps it is a little better. The outcome of the events was recovering.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>79</td>
                                    <td>2021-03-18</td>
                                    <td><strong>rash, skin spots</strong></td>
                                    <td>
                                        3-7-21 spouse first noticed red spots on face by spouse; also bloody nose later; pt stated that two ...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                3-7-21 spouse first noticed red spots on face by spouse; also bloody nose later; pt stated that two weeks prior (2-21-21) patient noticed spots on L leg (calf) and assumed it was a rash. Saw PCP on 3-8-21 at health clinic who dx petechiae and ordered a blood draw. Repeated blood draw 3-9-21. Transported via car to ER 3-10-21 and later tranferred where he was treated by hematologist. Patient dropped to 0 platelets
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>80</td>
                                    <td>2021-01-19</td>
                                    <td><strong>redness</strong></td>
                                    <td>
                                        Red area on the left side under the arm pit severe burn like a hot iron stating to heal 01/20/2021 p...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Red area on the left side under the arm pit severe burn like a hot iron stating to heal 01/20/2021 pealing
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>80</td>
                                    <td>2021-01-20</td>
                                    <td><strong>tingling</strong></td>
                                    <td>
                                        Patient reports intermittent left land paresthesias lasting about 10 minutes with a glove distributi...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Patient reports intermittent left land paresthesias lasting about 10 minutes with a glove distribution just in the hand initially on 1/16/21.  On 1/18/21, patient had symptoms lasting about 4 hours and could not pick up objects.  By the time he came to the ER for this, symptoms had resolved.  On Tues, 1/19, patient went skeet shooting and experienced an episode of numbness involving the entire left arm from shoulder to fingertips, involuntary hand movements, and left cheek twitching.  These symptoms lasted about 10 minutes.  Patient also reported dysarthria, slurred speech, strange sensation on left side of face, and facial asymmetry.   His wife reports his voice was a whisper and patient&#39;s left arm was dangling at his side.  Reports voice feeling weak along with these symptoms.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>80</td>
                                    <td>2021-01-20</td>
                                    <td><strong>injection site pain</strong></td>
                                    <td>
                                        Patient&#39;s wife called this morning stating that her husband has passed away last night. After receiv...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Patient&#39;s wife called this morning stating that her husband has passed away last night. After receiving first dose of Pfizer COVID-19 vaccine at around 0830, patient remained in the Immunizations Department for the 15-minute monitoring period. Per wife, patient&#39;s only complaint was pain at the injection site. At 1300, wife states that patient complaint of dizziness which &#34;dissipated after a few minutes&#34; followed by a headache which &#34;dissipated after a few minutes&#34; as well. Then patient complained of nausea, no vomiting and &#34;couldn&#39;t relax.&#34; Per wife, from around 1400/1500, patient stayed on his recliner while still having a conversation with her--&#34;he didn&#39;t get up to eat.&#34; Last conversation they had was around 2000/2100. Per wife, at around 2100/2200, patient was quiet and when she checked on him, &#34;he wasn&#39;t responding anymore.&#34; Wife then called 911, &#34;but they couldn&#39;t revive him.&#34;
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>80</td>
                                    <td>2021-01-27</td>
                                    <td><strong>rash, itchy skin</strong></td>
                                    <td>
                                        ITCHING TYPE OF RASH LEFT ARM, RIGNT KNEE, LEFT ANKEL
                                        
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>80</td>
                                    <td>2021-01-31</td>
                                    <td><strong>skin discolouration</strong></td>
                                    <td>
                                        Patient received first dose of the COVID-19 Moderna vaccine on 1/19/2021 at an outside facility (no ...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Patient received first dose of the COVID-19 Moderna vaccine on 1/19/2021 at an outside facility (no lot #, route, or site available to me in electronic charting).  Pt began having hypoxia, SOB, and a dusky appearance of extremities on 1/29/2021 and was brought by EMS to our hospital.  PT is a DNR and family had been looking into a hospice sign up due to dementia and general decline in the weeks prior to hospitalization.  Pt tested positive on admission for COVID-19 via PCR test on 1/29/2021.  Pt continued to have respiratory decline, was put on comfort care per wishes of family/advanced directives, and he passed away the evening of 1/30.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>80</td>
                                    <td>2021-02-14</td>
                                    <td><strong>itchy rash</strong></td>
                                    <td>
                                        rash all over his back and it itched like crazy and then started bleeding; rash all over his back an...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                rash all over his back and it itched like crazy and then started bleeding; rash all over his back and it itched like crazy; This is a spontaneous report from a contactable consumer (patient).  An 80-year-old male patient received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE) Lot # EK4176, via an unspecified route of administration on 23Jan2021 at single dose for covid-19 immunisation.  Medical history included heart disorder from an unknown date. Concomitant medications included a lot of medications for his heart and stuff. In Jan2021 the patient experienced rash all over his back and it itched like crazy and then started bleeding when he scratched. He received Benadryl tablets lotion on it as treatment. The outcome of the events was unknown.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>80</td>
                                    <td>2021-02-22</td>
                                    <td><strong>skin spots</strong></td>
                                    <td>
                                        Severe thrombocytopenia. Administration of dexamethasone and IVIG immune globulin. Petechiae over bi...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Severe thrombocytopenia. Administration of dexamethasone and IVIG immune globulin. Petechiae over bilateral lower extremities and feet. Ecchymosis.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>80</td>
                                    <td>2021-02-28</td>
                                    <td><strong>cellulitis</strong></td>
                                    <td>
                                        Patient is an 80 year old male who has a history of multiple medical problems, including body mass i...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Patient is an 80 year old male who has a history of multiple medical problems, including body mass index of 30, hypertension, dyslipidemia, giant-cell arteritis on a slow prednisone taper (currently 2 mg daily), past pulmonary embolism on warfarin, sleep apnea, history of diverticulitis (treated in August 2020), past abdominal surgeries (including umbilical hernia repair 2 and open recurrent incarcerated epigastric hernia repair with mesh in October 2020), chronic anemia, and type-2 diabetes.  The patient had received the first dose of the COVID-19 (SARS-CoV-2) vaccine on January 31, 2021 and the second dose on February 21.  He presented to his primary care provider?s office on February 22, 2021 with complaints of 10 days of progressive weakness and muscle soreness.  The weakness had reportedly involved the bilateral thighs and arms and was associated with muscle aches.  Blood pressure measured 90/40 mmHg and examination was notable for symmetrical proximal weakness in the upper and lower extremities.  The peripheral blood leukocyte count measured 3.5 x10e3/L, hemoglobin 8.3 grams per deciliter and platelets 147 x10e3/L.  A peripheral blood smear was consistent with neutropenia and normocytic anemia with 9% circulating blasts.  Total CK measured 1424 U/L.  The patient was referred to hematology/oncology and rheumatology and had appointment scheduled for both on February 26.    With the above background, he presented to emergency room on February 24 with altered mental status and continued weakness.   He was taken to the hospital by emergency medical services.  A temperature of 103 degrees Fahrenheit was recorded when emergency medical personnel had arrived. The peripheral blood leukocyte count was 1.4 x10e3/L for an ANC of 0.8 x10e3/L.  Hemoglobin was 8.1 g/dL and platelets 111 x10e3/L.  A few schistocytes and teardrop cells were noted. The serum creatinine was 1.47 mg/dL.  AST was 174, ALT 91 and alkaline phosphatase 93 U/L.  The lactic acid level of the venous blood was 2.1 mmol per liter.  A repeat total CK was 4631 U/L.  Sedimentation rate measured 34 mm/h and CRP 52.3 mg/L.  Urinalysis showed 0-2 wbc?s/hpf, 0-2 rbc?s/hpf, 3&#43; blood, negative nitrites, negative leukocyte esterase.  A haptoglobin level of the blood was within normal limits. The lactic acid level of the venous blood was 2.0 mmol/L.  LDH measured 838 U/L.  A ferritin level was 3464 nanograms/mL.  A test for COVID-19 (SARS-CoV-2) was negative.     A chest radiograph showed minimal streaky right basilar atelectasis, trace left effusion and a mildly enlarged cardiac silhouette.  A head CT showed no acute abnormality.  An abdominopelvic CT without contrast was limited by motion artifact.  No acute intra-abdominal or pelvic finding was noted.  Nonspecific soft tissue stranding was seen in the right inguinal region.  There was no soft tissue gas or drainable fluid collection.  Cultures of specimens of the blood were obtained.  The patient was started on empiric cefepime, vancomycin and doxycycline and admitted for further care. A peripheral blood smear for intracellular parasites was negative.  The admission blood cultures came back positive for E. coli. With the blood culture results, the vancomycin and doxycycline were discontinued.  The E. coli isolate has since been determined to be pansusceptible.  A MRSA PCR of the nares was negative.   He was found on exam to have swelling, cellulitis and exquisite pain of the right groin area on February 25.  Surgical consultation was pursued.  They did not feel that he had necrotizing fasciitis.  The CT scan of the abdomen and pelvis was repeated with contrast, revealing increased extensive subcutaneous edema of the right groin region with extension into the thigh musculature and mild extension into the right inferior pelvis.  There was no associated soft tissue gas or drainable abscess. A bone marrow biopsy was performed February 25.  Results showed acute undifferentiated leukemia with 60-70% infiltration of the bone marrow with blasts.  The blasts were negative for lineage markers.  He was faintly CD33 positive.  He is felt to likely have acute myeloid leukemia. Cytogenetics are pending.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>80</td>
                                    <td>2021-03-02</td>
                                    <td><strong>itchy skin</strong></td>
                                    <td>
                                        Moderate allergic reaction; itchy skin; itchy eyes; Headache; This is a spontaneous report from a co...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Moderate allergic reaction; itchy skin; itchy eyes; Headache; This is a spontaneous report from a contactable consumer. An 80-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL 9263), via an unspecified route of administration in right arm on 24Jan2021 11:45 at a single dose for COVID-19 immunization. Medical history included Diabetes2, HiBloodPress and HiCholesterol. Concomitant medication included lisinopril, simvastatin, and unspecified diabetes medication. On 26Jan2021, the patient experienced moderate allergic reaction, itchy skin, itchy eyes and headache. The patient was taking antihistamines with some relief for moderate allergic reaction, itchy skin, itchy eyes. There was no treatment for headache. The outcome of the events was recovering. Prior and since the vaccination, the patient was not tested for COVID-19. The events were assessed as non-serious.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>80</td>
                                    <td>2021-03-02</td>
                                    <td><strong>rash, shingles</strong></td>
                                    <td>
                                        bad body rash; shingles; This is a spontaneous report from a contactable consumer (wife). An 80-year...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                bad body rash; shingles; This is a spontaneous report from a contactable consumer (wife). An 80-year-old male patient (husband) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EL0142) via an unspecified route of administration in the right arm on an unspecified date (about three weeks ago) at a single dose for COVID-19 immunisation. There were no medical history and no concomitant medications. The reporter noted that both she and her husband took the Covid vaccine about 3 weeks ago, stated is time to take the second part. She read the pamphlet that came with it when we got the vaccine, said that a person could have a bad body rash. She stated her husband has had a bad body rash on an unspecified date. Noticed the rash right away, maybe the day or two after and it has persisted since, it was a nightmare for him, that she thought it was shingles on unspecified date. They went to the dermatologist and he told them it could be attributed to him eating red meat. The reporter wanted to know what they should do for it. Investigation assessment was noted as no. The outcome of rash was not recovered and of shingles was unknown.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>80</td>
                                    <td>2021-03-14</td>
                                    <td><strong>itchy rash</strong></td>
                                    <td>
                                        until the vein opened up and was squirting out blood; until the vein opened up and was squirting out...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                until the vein opened up and was squirting out blood; until the vein opened up and was squirting out blood; a severe itching rash; This is a spontaneous report from a contactable consumer. An 80-year-old male patient (reporter husband) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN5318), via an unspecified route of administration on 29Jan2021 12:00 at SINGLE DOSE in left arm for COVID-19 immunisation. Medical history included ongoing asthma Onset Date: Probably about 20 years ago, ongoing chronic obstructive pulmonary disease Onset Date: Probably about 20 years ago, ongoing overweight Illness/AE: Little overweight. There was none family medical history relevant to AEs. There were no concomitant medications. The patient received first dose of bnt162b2 (Lot number: EC3246) on 08Jan2021 in Left arm for COVID-19 immunization. The patient experienced a severe itching rash on 01Feb2021 with the outcome not recovered. Area where a vein is very close under the skin itching that he scratched until the vein opened up and was squirting out blood on 24Feb2021 with unknown outcome. The rash hasn&#39;t gotten worse, and it is staying the same. The AEs require a visit to: Emergency Room and Physician Office. The patient underwent lab tests and procedures which included biopsy: unknown results on 25Feb2021, Bloodwork: Nothing showed up on this test. This is a non-serious report. The outcome of event a severe itching rash was not recovered, outcome of the other events was unknown.  This consumer reported she and her husband were administered second dose of Pfizer COVID-19 Vaccine on 29Jan2021. Her husband apparently has had a reaction of very itchy rash to the Pfizer COVID-19 Vaccine. She reported that the patient saw the Dermatologist and the Dermatologist thinks the Reaction of very itchy rash is a reaction to the Pfizer COVID-19 Vaccine. Regarding testing/investigations related to this report caller provided that the primary care physician ordered bloodwork and nothing showed up in that. Biopsy was taken 25Feb2021 to see if reaction of very itchy rash is related to the Pfizer COVID-19 Vaccine When queried if any adverse event required Emergency room visit, physician&#39;s office visit or hospitalization caller reported that the patient was seen in the emergency room, but not admitted to the hospital on 24Feb2021 related to patient&#39;s event of area where a vein is very close under the skin itching that he scratched until the vein opened up and was squirting out blood event-they got that situated in the emergency room. Emergency room staff were the ones that recommended that the patient start Claritin. Dermatologist office visit was regarding the reaction of very itchy rash. The patient is taking Claritin and using Calamine lotion or Calamine spray for these events. Reaction assessed: Reaction of very itchy rash, Source of assessment: Primary Source Reporter, Method of assessment: Global Introspection, Drug result: Related.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>80</td>
                                    <td>2021-04-07</td>
                                    <td><strong>rash</strong></td>
                                    <td>
                                        Patient started having rash on his feet the same day and it was getting all over his body and also s...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Patient started having rash on his feet the same day and it was getting all over his body and also started swelling. he was even hospitalized. dr recommended not to get the second dose of covid vaccine
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>81</td>
                                    <td>2021-01-21</td>
                                    <td><strong>injection site pain</strong></td>
                                    <td>
                                        Sore arm at site Feeling flulike Very tired
                                        
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>81</td>
                                    <td>2021-01-22</td>
                                    <td><strong>redness</strong></td>
                                    <td>
                                        EMS brought patient to ED stating patient was bright red and tachypneic with oxygen saturation  of 8...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                EMS brought patient to ED stating patient was bright red and tachypneic with oxygen saturation  of 81-82% on RA. Failed on CPAP. Given Benadryl 50mg IVP, Solumedrol 125mg IVP, 0.3mg of IM Epi  and a duoneb with no relief. Was RSI&#39;d and intubated and transported to the ED.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>81</td>
                                    <td>2021-02-22</td>
                                    <td><strong>itchy rash, rash, skin discolouration, hives</strong></td>
                                    <td>
                                        Itchy rash all over the body.  Red pimples and streaks of red welts.
                                        
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>81</td>
                                    <td>2021-02-28</td>
                                    <td><strong>rash</strong></td>
                                    <td>
                                        Patient says that he has dermatitis; Rash; This is a spontaneous report from a contactable pharmacis...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Patient says that he has dermatitis; Rash; This is a spontaneous report from a contactable pharmacist and physician (patient himself). An 81-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE lot#: EL9261, exp date: May2021), via an unspecified route of administration on the left arm on 22Jan2021 15:30 at SINGLE DOSE for COVID-19 immunization.  Medical history and concomitant medications reported as none.  The pharmacist was calling to report that her father who had the Pfizer COVID-19 vaccine has a rash, a lot of a rash, after his first dose on 22Jan2021. No treatment was done for the rash. The pharmacist stated that her father though that the rash was a virus reaction.  Patient (father) abruptly takes over the phone call and confirmed that he was the patient. Patient stated that he has dermatitis (this was a virus reaction) on upper and lower limbs for two days after the injection of vaccine (at night for 3 hours every night). The patient stated it was a virus reaction and he was dermatologist, a dermatology specialist, he has been for 50 yearrs experience. Patient stated it was a slight reaction, 2-3 hours of rash and physical reaction. Outcome of the events were unknown.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>81</td>
                                    <td>2021-03-01</td>
                                    <td><strong>vaccination site pain, injection site swelling</strong></td>
                                    <td>
                                        injection site swelling; heart rate increased (95 bpm); jumping heart rhythm; Weakness; coughing whi...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                injection site swelling; heart rate increased (95 bpm); jumping heart rhythm; Weakness; coughing while trying to take a full breath; sore right arm; This is a spontaneous report from a contactable consumer reporting for himself. An 81-year-old male patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech, lot# EN6201), via an unspecified route of administration in the right arm, on 11Feb2021 at 11:45, at single dose, for COVID-19 immunisation. Medical history included ulcer haemorrhage, ongoing arthritis, blood pressure abnormal, coagulopathy, surgery (for his chronic arthritis in the neck and shoulder), cardiac disorder (with heart aneurysm and a murmur).  Concomitant medications included indapamide (unknown manufacturer) for blood pressure abnormal, acetylsalicylic acid (ECOTRIN 81 MG) for anticoagulant therapy, potassium (unknown manufacturer), candesartan (unknown manufacturer) for blood pressure abnormal, clorazepate dipotassium (TRANXENE) for muscle relaxant therapy for his chronic arthritis in the neck and shoulder. The patient experienced jumping heart rhythm on 15Feb2021 with outcome of not recovered, weakness on 15Feb2021 with outcome of recovered, coughing while trying to take a full breath on 15Feb2021 with outcome of recovered, sore right arm on 11Feb2021 with outcome of recovering, injection site swelling on an unspecified date with outcome of unknown, heart rate increased (95 bpm) on 15Feb2021 with outcome of unknown. The patient underwent lab tests and procedures which included heart rate: 95 bpm on 15Feb2021, prostatic specific antigen (PSA): unknown result on 03Feb2021. Therapeutic measures were taken as a result of sore right arm and included treatment with Tylenol.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>81</td>
                                    <td>2021-03-07</td>
                                    <td><strong>tingling</strong></td>
                                    <td>
                                        Tongue felt &#34;thick&#34;, cheeks tingled, and he developed chest pain.
                                        
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>81</td>
                                    <td>2021-03-14</td>
                                    <td><strong>vaccination site pain, vaccination site redness</strong></td>
                                    <td>
                                        he tested COVID-19 positive; he tested COVID-19 positive; fever and chills; fever of 100.5; takes al...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                he tested COVID-19 positive; he tested COVID-19 positive; fever and chills; fever of 100.5; takes all his energy to walk around or eat or do anything; injection site turned red and sore; injection site turned red and sore; The initial safety information received was reporting only non-serious adverse drug reactions, Upon receipt of follow-up information on 15Feb2021, this case now contains serious adverse reaction. Information processed together.  This is a spontaneous report from a Pfizer-sponsored program received from a contactable consumer (patient). An 81-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL2347), intramuscularly, in the left arm, on 29Jan2021 at 11:00 at single dose for COVID-19 immunisation. Medical history included esophageal cancer from 2020, had major surgery from an unknown date about 4 months ago, and a third of his esophagus was taken out from an unknown date. There were no concomitant medications. No history if immunizations were provided. No other vaccines within 4 weeks prior to vaccination. The patient had the first dose on 29Jan2021 at 11:00 at a site sponsored by the health department, on 12Feb2021, it was reported that patient tested COVID-19 positive. On 31Jan2021, the patient reported that he had chills and a fever of 100.5, a couple times his fever spike up and goes away. He does not want to do anything since it takes all his energy to walk around or eat or do anything. On 29Jan2021, after the injection, the patient reported injection site turned red and got sore. He is asking how long the symptoms last. The events did not require physician&#39;s office or emergency room visit. No treatment was given. The outcome of the events injection site turned red and sore was recovered while for the rest of the events was unknown. The patient was asking if he should get the second dose.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>82</td>
                                    <td>2021-01-14</td>
                                    <td><strong>rash, itchy rash</strong></td>
                                    <td>
                                        rash on torso....itching
                                        
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>82</td>
                                    <td>2021-01-15</td>
                                    <td><strong>rash</strong></td>
                                    <td>
                                        Face swollen- burning sensation on face- rash all over face
                                        
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>82</td>
                                    <td>2021-01-24</td>
                                    <td><strong>hives</strong></td>
                                    <td>
                                        Swollen lip; Hives near the groin area; This is a spontaneous report from a contactable consumer (pa...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Swollen lip; Hives near the groin area; This is a spontaneous report from a contactable consumer (patient&#39;s daughter).  An 82-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL3246), via an unknown route of administration, at single dose on 12Jan2021 for COVID-19 immunisation. Relevant medical history included gout and sinuses. The patient did not have relevant concomitant medications.On 12Jan2021, after vaccination, the patient had swollen lips and he thinks like hives on his thought near his groin, on the upper inside of his thighs on both sides, like hives, with swelling but not a rash. She said her father put hydrocortisone cream on his thighs and they were getting better. She said the lip swelling had not gone down, he took an allergy pill for that, he did not apply cream to his lips. She clarified that the hydrocortisone cream was brand Equate 1% Hyrdocortisone Maximum Strength Cream (UPC 319162ET4, Batch: 8JT0419, and EXP Aug2021). She reported that the allergy pill was generic Equate Allergy Relief (UPC: Unknown, LOT P121359, EXP Aug2022). The patient was recovering from the events.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>82</td>
                                    <td>2021-02-10</td>
                                    <td><strong>tingling</strong></td>
                                    <td>
                                        hearing is off/his ears feel like they&#39;re full of water so he can&#39;t really hear; lost his voice; diz...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                hearing is off/his ears feel like they&#39;re full of water so he can&#39;t really hear; lost his voice; dizziness/Really dizzy; bottom of the feet is tingling; Slightly blurry vision; This is a spontaneous report from a contactable consumer (caregiver). An 82-years-old male patient (Father) received first dose of BNT162B2 (BNT162B2, lot number: EL1283), via an unspecified route of administration in left arm on 24Jan2021 13:30 at SINGLE DOSE as Scared to death to get COVID. Medical history included ongoing High blood pressure. Family history included Father died of melanoma. Concomitant medication included ongoing lisinopril (strength: 10mg) for High blood pressure. Caller stated her father received the pfizer covid vaccine first dose on this Monday and have weird side effects, he lost his voice, dizziness/ Really dizzy, hearing is off/ Ears feel like they&#39;re full of water so he can&#39;t really hear, bottom of the feet is tingling/ tingling in his feet and slightly blurry vision. Caller wanted to know if it is normal. Caller also said safety department told her to speak to quality department about the shot her farther received is it a bad batch or not. No visit to Emergency Room and Physician Office. The outcome of the events was not recovered.  No follow-up attempts possible. No further information expected.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>82</td>
                                    <td>2021-03-02</td>
                                    <td><strong>tingling, redness</strong></td>
                                    <td>
                                        Right arm achy/a little achy/only his arm was achy/arm only hurt when he was lying on it; Right ear ...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Right arm achy/a little achy/only his arm was achy/arm only hurt when he was lying on it; Right ear ache and bumps around ear lobe/ear started hurting/earache/behind his ear started hurting. Going online and believes irritation could be from the masks worn for COVID-19.; Back of his ear was red and swollen/around left ear lobe it is bump and red; Back of his ear was red and swollen/around left ear lobe it is bump and red; Back of his ear was red and swollen/around left ear lobe it is bump and red; Tingling to his ear; lesions are at the top of his ear near his hairline; This is a spontaneous report received from a contactable consumer (patient). An 82-year-old male patient received the first shot of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1283, expiry date: unknown), via an unspecified route of administration on the right arm, on 25Jan2021 11:10, at single dose, for COVID-19 immunization/Want to live, at the hospital. Medical history included being allergic to cats; had triple bypass and valve, had allergies his whole life and had shrunk. Concomitant medications included unspecified allergy pills which the patient takes all year round. The patient previously took amoxicillin and reported that he was immune to it and it did not work; reported that he has taken azithromycin before when he goes to the dentist he has to take azithromycin. On 25Jan2021, the patient took his first COVID-19 vaccine shot. On the same day, the patient was a little achy. He took Tylenol every 5 hours afterwards and iced it and then had had no problem. He woke up the next morning (26Jan2021) perfectly fine. The patient clarified that only his arm was achy, his right arm was achy, and it only hurt when he was lying on it. But then on Wednesday night or Thursday morning (Jan2021), the patient had tingling to his ear and the back of his ear was red and swollen. He reported that &#34;behind his ear started hurting&#34;. He also had right earache and bumps around ear lobe. He reported he had little bumps or lesions which were at the top of his ear near his hairline. The patient went to his pharmacist to get their opinion and was given Aquaphor ointment for pain relief, but he reported that it made the area behind his ear worse, so he went back to using the antibiotic ointment and stated that &#34;the cold pack helped the most&#34;. The patient reported had doctor&#39;s appointment on 01Feb2021 at 12 and the doctor gave him azithromycin tablets, 6 tablets. He also reported that he has an unopened box of Azithromycin tablets USP which he has not taken and will not without doctor&#39;s permission. He went online and believes this irritation behind the ear could be from the masks worn for COVID-19 and stated that the KN-95 masks were kind of tight. He stated he now has the thing on the back of his neck to help with the mask. The patient also reported that he doesn&#39;t have fever or temperature and he has no cold. The patient was scheduled to receive his second shot two weeks from the time of the report and wanted to know if he can take antibiotics and then get the second shot. The patient recovered from pain in arm on 26Jan2021; and has not recovered from the remaining events.; Sender&#39;s Comments: Event ear pain represents an intercurrent medical condition and unrelated to BNT162B2 .
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>82</td>
                                    <td>2021-03-11</td>
                                    <td><strong>blister</strong></td>
                                    <td>
                                        Pemphigus; blisters over upper body; This is a spontaneous report from a contactable physician. An 8...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Pemphigus; blisters over upper body; This is a spontaneous report from a contactable physician. An 82-year-old male patient received his second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EK9231), via an unspecified route of administration on left arm on 20Jan2021 at SINGLE DOSE for covid-19 immunisation. Medical history included glaucoma, AMD and arrhythmia. Concomitant medication included nebivolol hydrochloride (BYSTOLIC), rosuvastatin calcium (CRESTOR) and timolol. The patient received his first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: lot number: EL 1284 on left arm) on 30Dec2020 for covid-19 immunisation and experienced hives in the back. The patient experienced pemphigus and blisters over upper body on 18Feb2021 12:00. The patient underwent lab tests and procedures which included Skin Bx: confirm pemphigus on an unspecified date. Therapeutic measures were taken as a result of pemphigus and blisters included prednisone. Outcome of the events was not recovered.; Sender&#39;s Comments: Based on the information currently available, a possible contributory role of the suspect drug to the reported events &#34;Pemphigus and blisters over upper body&#34; cannot be completely excluded based on temporal association.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identifies as part of this review, as well as any appropriate action in response, will be promptly notifies to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>82</td>
                                    <td>2021-03-15</td>
                                    <td><strong>hives</strong></td>
                                    <td>
                                        Pemphigus; Hives in the back; This is a spontaneous report from a contactable physician (patient). A...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Pemphigus; Hives in the back; This is a spontaneous report from a contactable physician (patient). An 82-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EL 1284), via an unspecified route of administration, on the left arm, on 30Dec2020 at a single dose for Covid-19 immunisation. Medical history included glaucoma, age-related macular degeneration (AMD), arrhythmia. The patient has no known allergies. The patient did not receive other vaccine in four weeks. The patient has no Covid prior vaccination and not Covid tested Concomitant medications included nebivolol hydrochloride (BYSTOLIC), rosuvastatin calcium (CRESTOR), and timolol.  On an unspecified date, the patient developed hives in the back within a week after 1st shot and broke out in blisters over upper body 3 wks after 2nd shot of vaccine. Skin biopsy (Bx) done to confirm Pemphigus. Treatment for the events was Kenalog 60 mg IM/ also 3 wks later prednisone po. The outcome of the events was not recovered.; Sender&#39;s Comments: Based on the information currently available, a possible contributory role of the suspect drug in the reported event Pemphigus cannot be completely excluded given the known suspect drug profile and/or implied temporal association. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regul atory Authorities, Ethics Committees and Investigators, as appropriate.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>82</td>
                                    <td>2021-03-26</td>
                                    <td><strong>itchy skin</strong></td>
                                    <td>
                                        Patient received his first dose of Pfizer COVID-19 vaccine on 02/03/2021. He has significant medical...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Patient received his first dose of Pfizer COVID-19 vaccine on 02/03/2021. He has significant medical history, but presented to the hospital on afternoon of 02/08/2021 with report of three days of nausea and vomiting. He thought this attributed to a new cholesterol medication. He also reported some shortness of breath, mild cough, no fever. reported some epigastrium pain the day prior but since resolved.  Significant other reported some significant swelling and that pt complained of feeling like he had a &#34;blockage in his throat&#34;. Workup showed concerns of pneumonia so pt was started on antibiotics and Vitamin K. Shortly after meds started pt started complaining of itching arm and trouble breathing. He became bradycardic and lost consciousness. Resuscitative efforts initiated but unsuccessful. Time of death called on 02/08/2021 at 1737. Hospital notes report &#34;cause of death is anaphylaxis&#34;, and pt would be an OME case.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>83</td>
                                    <td>2021-01-10</td>
                                    <td><strong>injection site swelling</strong></td>
                                    <td>
                                        injection site  was red and enlarged and looked wet
                                        
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>83</td>
                                    <td>2021-01-15</td>
                                    <td><strong>redness, hives, rash, itchy skin</strong></td>
                                    <td>
                                        twenty six hours after vaccine, hands started itching. Progressed to hive type rash from waist up. A...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                twenty six hours after vaccine, hands started itching. Progressed to hive type rash from waist up. Also arms from elbows to hands. Face and eyes turned red. Fifty mg of Benadryl taken every six hours times three. This morning went to a walk in clinic . Was put on a Prednisone taper over 5 days.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>83</td>
                                    <td>2021-02-28</td>
                                    <td><strong>vaccination site pain</strong></td>
                                    <td>
                                        slight pain in his arm the shot was given; if he moved his arm, he would have slight discomfort; som...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                slight pain in his arm the shot was given; if he moved his arm, he would have slight discomfort; some slight tenderness in his shoulder; Yesterday, his temperature was 97 something. This morning, he got up at 6am and his temperature was around 98.8; This is a spontaneous report from a contactable consumer (patient). An 83-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9261; expiry date: unknown) via an unspecified route of administration in the left arm, on 26Jan2021 at 8:30 to 9 AM, at a single dose, for Covid-19 immunization. Medical history in Mar2020 included had a temperature for 7 days. He tested positive for COVID and it took a while to test negative. At the end of Mar2020 until the first of Apr2020, his temperature was 97 something. He has checked his temperature every day since then. There were no concomitant medications. The patient had no previous immunization with the Pfizer vaccine. He did not receive additional vaccines on the same date bnt162b2 was given. The patient had his first COVID-19 shot yesterday morning about 8:30 or 9:00. He hadn&#39;t really looked at the list of side effects, but yesterday afternoon (26Jan2021), he had slight pain in the arm where the shot was given. If he moved his arm, he would have slight discomfort. The pain was mostly gone today. He also had some slight tenderness in his shoulder, but it&#39;s certainly less than what it was yesterday. He saw other things that were listed including fever. He wanted to know if Pfizer had any information as what to amount of fever people typically experience after having the shot.  Yesterday (unspecified date in Jan2021), his temperature was 97 something. This morning, he got up at 6 am and his temperature was around 98.8. And then he had to take his wife to therapy and when he got back 3 hours later, he took it now and his temperature was 99 degrees. He was just wondering if Pfizer had an idea of how much fever is normal from the shot?  He hasn&#39;t had any other reactions. The events did not require Emergency Room or Physician&#39;s Office visit. The patient underwent lab tests and procedures which included body temperature: 97 something on 26Jan2021, 98.8 and 99 on 27Jan2021; sars-cov-2 test: positive on an unspecified date in 2020 and negative on an unspecified date in 2020. Outcome of the event &#34;slight pain in his arm the shot was given&#34; was recovering, while for the other events was unknown.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>83</td>
                                    <td>2021-03-14</td>
                                    <td><strong>rash, skin discolouration</strong></td>
                                    <td>
                                        its bluish in color and it looks like there is bleeding under the skin; noticed his reaction/an area...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                its bluish in color and it looks like there is bleeding under the skin; noticed his reaction/an area on the inside of his right thigh that looks like a hematoma; he has like a hematoma almost like a discoloration of the skin on the inside of his thigh/purplish color, like a bluish reddish but it is not red.; rash on the inside of his thigh. He clarifies well it is not a rash it is more like a hematoma; This is a spontaneous report from a contactable consumer (patient himself). An 83-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Batch/lot number: EN6198), via an unspecified route of administration on the left arm, first dose at age 83 years, on 25Feb2021 at single dose for COVID-19 immunisation. Medical history was reported as none. There were no concomitant medications. Patient stated that he got the Pfizer COVID 19 Vaccine yesterday (25Feb2021) at noon and this morning (26Feb2021), he has a rash on the inside of his thigh. He clarifies well it is not a rash it is more like a hematoma, almost like discoloration of the skin, it doesn&#39;t hurt but he wants to see if this is something that normally occurs. He showered last night and didn&#39;t notice it until this morning. He only noticed it about a half hour ago so he is not sure if there is any difference. He clarifies the area on the inside of his thigh is a purplish color, like a bluish reddish but it is not red. It looks like a hematoma, like bleeding under the skin. There is no swelling, it is not raised and it doesn&#39;t hurt to touch, just there. He didn&#39;t call his primary about this. He got this information so his doctor does not know anything about it. If it is something to be concerned about he will run down to the emergency room but he will see if he can find the office contact info. Outcome of the events was not recovered. Case was reported as non-serious.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>83</td>
                                    <td>2021-03-18</td>
                                    <td><strong>itchy skin</strong></td>
                                    <td>
                                        Didn&#39;t realize what was going on; Whole body felt like itching, whole body was just feeling funny; F...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Didn&#39;t realize what was going on; Whole body felt like itching, whole body was just feeling funny; Feet are numb and cold; Feet are numb and cold; Ended up in the emergency room because I was having some problems with chest pain; heart problems; Sick all day Saturday, all day Sunday, and most of Monday; This is a spontaneous report from a contactable consumer (patient). An 83-year-old male (also age at vaccination) patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), second dose via an unspecified route of administration, administered in Arm Right (reported as Right upper arm) on 27Feb2021 (Batch/Lot Number: EN6205) as SINGLE DOSE for covid-19 immunization. Medical history reported that &#34;I have had one stent and one angioplasty done. Stent was done last year in 2020 and angioplasty was done in &#39;1990&#39; (not confirmed).&#34; The patient also added &#34;I gained a bunch of weight when I had my thyroid removed.&#34; The patient previously took the first dose of bnt162b2 on unspecified date for Covid-19 immunization. For the concomitant medication the patient stated, &#34;Yes, I am taking medications.&#34; (specified medications not reported/ provided). It was reported by the patient that, &#34;I got this, my second COVID-19 Vaccine shot Saturday morning. All day Saturday (27Feb2021), all day Sunday and most of Monday, I was so sick, I didn&#39;t realize what was going on. Yesterday (02Mar2021), I ended up in the emergency room because I was having some problems with chest pain. So, I presume this is all connected to the second shot I got.&#34; It was added by the patient, &#34;I am asking question. About an hour or less than an hour ago I woke up, and my whole body felt like it was itching. I mean my whole body was just feeling funny. I was itching all over, that went away, I took a pill a while ago for that. &#39;Lorazepam&#39; (not confirmed over the call), it&#39;s a nerve, anxiety pill and it kind of helped. But right now, my feet are numb and cold.&#34; For the laboratory test the patient stated that, &#34;Yes they did a lab test on me yesterday (02Mar2021) as I went to the emergency room with some heart problems. They did blood work, that&#39;s all they did.&#34; The patient reported for the results, &#34;They said everything was fine.&#34; The outcome of the events was unknown. The patient explained that &#34;No, I didn&#39;t take any medication for that.&#34; However treatment was received for Whole body felt like itching, whole body was just feeling funny.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>84</td>
                                    <td>2021-01-15</td>
                                    <td><strong>injection site pain</strong></td>
                                    <td>
                                        Pain @ injection site; muscle pain, shortness of breath, fast heart beat, difficulty breathing, vomi...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Pain @ injection site; muscle pain, shortness of breath, fast heart beat, difficulty breathing, vomiting at 4:45 am and at 5:40 am on 1/16/21.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>84</td>
                                    <td>2021-02-21</td>
                                    <td><strong>tingling</strong></td>
                                    <td>
                                        A short time after the injection a tingley, prickley feeling went down both arms and legs to my hand...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                A short time after the injection a tingley, prickley feeling went down both arms and legs to my hands and feet.  I felt normal otherwise. The intensity varies but is always there. My doctor could find no serious problem and suggested a possible B12 connection and ordered a blood test.  The test showed my B12 went from around 200 to over 1000.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>84</td>
                                    <td>2021-03-01</td>
                                    <td><strong>skin reaction, vaccination site pain</strong></td>
                                    <td>
                                        sore at inj. site; breaking out on legs and top of feet; This is a spontaneous report from a contact...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                sore at inj. site; breaking out on legs and top of feet; This is a spontaneous report from a contactable consumer (patient himself). An 84-year-old male patient receive the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: not available), via an unspecified route of administration on the left arm, on 28Jan2021 at 14:15 at single dose for COVID-19 immunisation. Medical history included diabetes and allergies, both from an unknown date. Concomitant medications included unspecified &#34;regular meds.&#34; On 29Jan2021 at 19:00, it was reported that the patient experienced sore at inj. site and breaking out on legs and top of feet. No treatment was received. The events were considered as non-serious by the reporter. The events did not lead to death, life-threatening condition, hospitalization, disabling/incapacitating, or congenital anomaly. The patent has not been diagnosed with COVID 19 prior to vaccination and has not been tested for COVID-19 since vaccination. The patient did not receive any other vaccines within 4 weeks prior. The outcome of the events was unknown. The patient was vaccinated at a hospital.   Information on the lot/batch number has been requested.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>85</td>
                                    <td>2021-01-14</td>
                                    <td><strong>itchy skin</strong></td>
                                    <td>
                                        itching; bottom lip was swollen; This is a spontaneous report from a contactable consumer via the Me...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                itching; bottom lip was swollen; This is a spontaneous report from a contactable consumer via the Medical Information Team. An 85-year-old male patient started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from an unspecified date at a single dose for an unspecified indication. Medical history included hard of hearing. The patient&#39;s concomitant medications were not reported. It was reported that the patient started itching and bottom lip was swollen. Bottom lip swelling has gone down today but she has still itching all over the body. She tried Benadryl but not helping. The outcome of the event itching was not recovered while recovering for the other event. Information about Lot/Batch has been requested.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>85</td>
                                    <td>2021-01-31</td>
                                    <td><strong>rash, itchy skin</strong></td>
                                    <td>
                                        itchy rash in b/l arms. itch resolved after 3 hours, and skin became scaly and peeling in tiny patch...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                itchy rash in b/l arms. itch resolved after 3 hours, and skin became scaly and peeling in tiny patches about 0.5 cm, multiple, across b/l arms.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>85</td>
                                    <td>2021-02-22</td>
                                    <td><strong>bruising</strong></td>
                                    <td>
                                        Feb 9, patient was light-headed, as if he was going to faint. He did not have appetite. Evening of F...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Feb 9, patient was light-headed, as if he was going to faint. He did not have appetite. Evening of Feb 9, started vomiting large amounts of blood. Ambulance took him to hospital. CT scans showed abnormally enlarged pancreas. Patient aspirated blood and was put on a ventilator for 48 hrs. Endoscopic ultrasound showed ulcers in stomach that appear to have been bleeding, which were clipped and shot with epinephrine. After being treated for ulcers, patient developed blood clots in leg and lungs. It is almost two weeks since initial emergency, and patient is still showing sings of internal bleeding (low blood pressure, low hemoglobin, blood in stool). Still no firm explanation for continued bleeding. Before adverse event on Feb 9, patient did not report other symptoms from shot, however, he did show unusual signs of large bruising on his arm. Patient is currently at Hospital. Blood thinners are being discontinued, but patient still has blood clots.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>85</td>
                                    <td>2021-02-22</td>
                                    <td><strong>redness</strong></td>
                                    <td>
                                        Localized redness and nodule s/p vaccine administration. Pt A/Ox4, Skins normal for ethnicity. Resp ...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Localized redness and nodule s/p vaccine administration. Pt A/Ox4, Skins normal for ethnicity. Resp unlab and even. NAD. Denies any other s/sx at this time. Ice pack applied to site.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>85</td>
                                    <td>2021-02-27</td>
                                    <td><strong>rash, injection site rash</strong></td>
                                    <td>
                                        Narrative:  Patient received COVID/Pfizer #1 2/10/21 in L deltoid. (Patient home bound). On 2/12/21 ...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Narrative:  Patient received COVID/Pfizer #1 2/10/21 in L deltoid. (Patient home bound). On 2/12/21 reported left flank rash. 2/13 rash spread to entire abdomen/chest and UEs. Continued with fluctuations in BP/HR, fluid retention. On 2/16 labs ordered and Medrol dose pack. seen in home on 2/19 by MD - RUE swelling; diffuse rash over entire body; additional labs ordered (order to home infusion company). Patient passed in AM of 2/20/21. Reported no urine output the prior evening. Additional labs not performed due to death of patient prior to lab company arrival.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>86</td>
                                    <td>2021-01-25</td>
                                    <td><strong>rash</strong></td>
                                    <td>
                                        Rash - treatment antihistamines
                                        
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>86</td>
                                    <td>2021-02-17</td>
                                    <td><strong>rash</strong></td>
                                    <td>
                                        bleeding internally in small intestine; cut Eliquis in half; rash on shoulder and neck; This is a sp...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                bleeding internally in small intestine; cut Eliquis in half; rash on shoulder and neck; This is a spontaneous report from a contactable consumer based on information received by Pfizer from Bristol-Myers Squibb (manufacturer control number: US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-013205) license party for apixaban (ELIQUIS).  This case was received via Pfizer Inc (Reference number: 2021125505) on 05-Feb-2021 and was forwarded to BMS on 08-Feb-2021. This spontaneous case was reported by a consumer and describes the occurrence of SMALL INTESTINAL HAEMORRHAGE (bleeding internally in small intestine) in 86-year-old male patient who received apixaban (Eliquis) tablet for an unknown indication. The occurrence of additional non-serious events is detailed below. CO-SUSPECT PRODUCTS included Covid-19 Vaccine for Prevention. Product or product use issues identified: WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (cut Eliquis in half). Concurrent medical conditions included Gout (diagnosed two or three years ago). On an unknown date, the patient started Eliquis (Oral) 2.5mg half tablet by mouth twice daily. On 07-Jan-2021, the patient started Covid-19 Vaccine (Intramuscular) intramuscular injection in right arm. Further treatment periods at the same dose started on 01-Feb-2021. In January 2021, the patient experienced RASH (rash on shoulder and neck). On an unknown date, the patient experienced SMALL INTESTINAL HAEMORRHAGE (seriousness criterion medically significant). The patient was treated with salicylic acid (Eucerin [Salicylic Acid]) for Rash. The action taken with Eliquis(Oral) was unknown. At the time of the report, SMALL INTESTINAL HAEMORRHAGE outcome was unknown and RASH did not resolve. Cardiologist recommended patient to take apixaban for palpitation of the heart that he has every so often. Eliquis at 2.5mg tablet twice a day and then patient found out he was bleeding to death, clarifies he was bleeding internally in his small intestine. So he cut his Eliquis in half and he was currently taking half of 2.5mg tablet twice a day. He got the Pfizer covidl19 shot. He has developed a rash on his shoulder and neck. He also stopped using his laundry soap since he was not sure if it was his laundry soap. For Eliquis(Oral), the reporter did not provide any causality assessments.; Sender&#39;s Comments: BMS Medical Evaluation Comment: This patient had small intestine hemorrhage while on apixaban. Based on the anticoagulant nature of apixaban, its contributory role in small intestine hemorrhage is considered possible.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>86</td>
                                    <td>2021-03-21</td>
                                    <td><strong>cellulitis</strong></td>
                                    <td>
                                        2/27/21 hpi86 y.o. male with a past medical history notable for  Dementia, hypertension, hyperlipide...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                2/27/21 hpi86 y.o. male with a past medical history notable for  Dementia, hypertension, hyperlipidemia, recent skin breakdown. The patient presents for evaluation of worsening issues of cellulitis and acute renal failure skilled care facility. Due to patient&#39;s dementia other history could not be taking. Patient has had decreased intake. Patient has had some worsening issues with skin breakdown. Patient&#39;s past medical history, past surgical history, social history, family history, medications allergies were reviewed. Patient does show signs of discomfort with his bottom. Patient otherwise appears to be at baseline.  Hospital Course:    patient was admitted to the hospital for worsening dehydration and  finding UTI and pneumonia. The patient is also found have skin breakdown. The patient was placed and patient is started on IV fluids and IV antibiotics and wound care was started on patient. Patient did have some issues with behaviors but this was improved with treatment.  3/20/21 readmission acute renal failure
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>87</td>
                                    <td>2021-01-19</td>
                                    <td><strong>rash</strong></td>
                                    <td>
                                        Received Pfizer Covid vaccine on January 13, 2021.  I noticed a rash across shoulders and back on 1/...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Received Pfizer Covid vaccine on January 13, 2021.  I noticed a rash across shoulders and back on 1/15/21.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>87</td>
                                    <td>2021-02-18</td>
                                    <td><strong>injection site pain</strong></td>
                                    <td>
                                        death Narrative: 86 year old MALE with PMH of Afib s/p AICD/PPM, HFrEF (EF&lt; 20% 10/2019), DM2, HTN, ...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                death Narrative: 86 year old MALE with PMH of Afib s/p AICD/PPM, HFrEF (EF&lt; 20% 10/2019), DM2, HTN, HLD, BPH, Depression. Was stable and feeling well when he was administered Covid-19 vaccine on 02/17/2021- Pfizer COVID-19 Vaccine 0.3 ml IM. MVX (Manuf); PFR; Lot#; EL9267; Exp Date:05/31/2021 Administration Anatomic site: Right Deltoid; Pt was monitored for 30 minutes after administration and had no adverse effects. He was called later in the day and reports he feels well and has had no adverse reactions, he endorsed his arm is a little sore at injection site. ON 02/19/2021- his dghter found him on the floor, next to his bed, dead. She reported on 2/19/2021- that she was out with him to dinner on 2/18/2021, and he stated he did not feel well, that his insides did not feel right. He proceeded to have dinner and 2 drinks. HE was doing ok, when she took him home.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>87</td>
                                    <td>2021-02-23</td>
                                    <td><strong>bruising</strong></td>
                                    <td>
                                        fall; bruised rib; bruised hip; This is a spontaneous report from a contactable consumer (reporting ...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                fall; bruised rib; bruised hip; This is a spontaneous report from a contactable consumer (reporting for his father). An 87-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK9231, expiration date: 30Apr2021), via an unspecified route of administration into the left arm on 12Jan2021 at a single dose for COVID-19 immunisation (COVID prevention). The patient&#39;s medical history included Alzheimer&#39;s disease and stroke. There were no concomitant medications. The reporter was calling regarding his father who was an 87-year-old combat veteran. The reporter stated that the patient received the first dose of the Pfizer COVID Vaccine on 12Jan2021. The patient was scheduled for his second dose on 02Feb2021, but they had to cancel that appointment because the patient was in the hospital from a fall he had on 29Jan2021 where he bruised his hip and bruised his rib. The patient was hospitalized from 30Jan2021 and was released from the hospital on 05Feb2021. The reporter stated that the clinic said they are not able to make any more appointments right now. The reporter was wondering if there were consequences of, or a danger in, getting the second dose outside of the recommended timeframe. The patient is now on a waiting list to get the second dose and he would like to know how far past the recommended 21 days can he go and still have the vaccine be effective. The patient received no other vaccines on the same day as the COVID vaccine. The patient has had an MRI before where it was indicated that there were some spots from a past stroke. The reporter stated that no paralysis has been identified. The outcome of the events was unknown.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>88</td>
                                    <td>2021-01-04</td>
                                    <td><strong>rash</strong></td>
                                    <td>
                                        Vaccine given on 12/29/20 by Pharmacy. On 1/1/21, resident became lethargic and sluggish and develop...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Vaccine given on 12/29/20 by Pharmacy. On 1/1/21, resident became lethargic and sluggish and developed a rash on forearms. He was a Hospice recipient and doctor and Hospice ordered no treatment, just to continue to monitor. When no improvement of codition reported, doctor and Hospice ordered comfort meds (Morphine, Ativan, Levsin). Resident expired on 1/4/2021
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>88</td>
                                    <td>2021-03-02</td>
                                    <td><strong>vaccination site pain</strong></td>
                                    <td>
                                        he is coughing now; soreness in muscle on site on injection; This is a spontaneous report from a con...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                he is coughing now; soreness in muscle on site on injection; This is a spontaneous report from a contactable consumer. An 88-year-old male patient (husband) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/lot number: EL9261, expiry date: May2021), intramuscular on 23Jan2021 11:30 AM at 0.3 mL, single on left deltoid (reported as &#34;0.3ml by IM (intramuscular) injection once to in left shoulder, the usual place&#34;) for COVID-19 immunisation (reported as &#34;88 and they are not anxious for him to get COVID/he has deep lung disease and if he didn&#39;t get it, he may die from it&#34;).  Vaccination facility type was a special clinic set up by hospital. Vaccine was not administered at facility. Medical history included deep lung disease, total reverse shoulder surgery in Jul2020, asthmatic, lung problems. Patient has no compromised immune system. Patient&#39;s only allergic reaction was old tetanus (tetanus toxoid) but he was really fine. Patient had tetanus toxoid in 1950, he was a very young man and he has not had it since then, the reporter does not believe they give it anymore. No family medical history relevant to adverse events, also reported as &#34;No, but there is no history for the COVID vaccine, we are only 3 months into it&#34;. Concomitant medication included omalizumab (XOLAIR) for lung problems and asthmatic. No additional vaccines administered on same date of Pfizer product. After the first 3 days, patient got the vaccine on 23Jan2021. Patient is now on day 9 but the first 3 days after, he had no side effects. On the 4th day (27Jan2021), he developed soreness in his muscle on the site of injection, and the next day it was increasingly sore, on the 28Jan2021, 29Jan2021, 30Jan2021, and was quite incapacitated, he could not use it, it was really bad, now he was beginning to improve. The reporter wanted to Pfizer to know the length and depth. It only had to do with the use of the muscle not, he was not suffering when not using the arm, a couple days were really bad, he did feel it when he was not using it, but most of the time, the pain came when he needed to use it. The reporter talked to enough who said don&#39;t worry, but patient had a total reverse shoulder surgery in Jul2020, in that arm and asked &#34;could that injection exacerbate anything going on there?  Most doctors said to not worry about it&#34;. The reporter wants to help COVID. The reporter got hers minute after his husband and she had no side effects whatsoever, so if there was any question about something going on at the site, she could not imagine hers would be so perfect. The event did not require emergency room and physician office visit, further reported that patient had multiple health issues. Patient was coughing now(01Feb2021), over the years, reporter has learned to deal with many things without going to Urgent Care, ER, patient was 88 and the reporter wanted to keep his husband out due to COVID. The reporter called friends who were medical doctors (MDs), as the reporter was worried, the patient was coming out of it. Patient has one injection, a new medication he was on a biologic. Patient was first refused to get the COVID vaccine due to biologic, and the day before he had received it, so they discussed and decided because of biologic, &#34;XOLAIR&#34;. There were no adverse events prior vaccinations. Patient went on Friday for his next Xolair, he had no problems then. There were no relevant tests and was reported that patient has been there the whole time, at home, has been under quarantine since last Mar2020. If anything threw up a red flag, reporter would think it would be something they would explore, maybe for the Xolair, when this question came up, it was several days before the vaccine, patient was refused. Patient was asked if there were other injections, reporter said that his husband would have &#34;one the one day before&#34;, and they canceled his appointment, and he went to the doctor, the pulmonologist, who administered Xolair, and reporter said that his husband was refused, the doctor said no, &#34;it&#39;s a biologic, he was giving it to patients having the COVID vaccine, there were no interactions, and reinstated approval and everything was a go&#34;. Outcome of the event &#34;soreness in muscle on site on injection&#34; was recovering while for coughing was unknown.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>88</td>
                                    <td>2021-03-21</td>
                                    <td><strong>injection site redness</strong></td>
                                    <td>
                                        Redness of the left arm at site. Dehydration, hypotension, falls, confusion.
                                        
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>88</td>
                                    <td>2021-03-22</td>
                                    <td><strong>cellulitis</strong></td>
                                    <td>
                                        Cellulitis; Four redness with purplish lesions to the upper arm almost to antecubital; This is a spo...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                Cellulitis; Four redness with purplish lesions to the upper arm almost to antecubital; This is a spontaneous report from a contactable nurse. An 88-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6202), dose 1 via an unspecified route of administration on 26Feb2021 as single dose, for COVID-19 immunisation. The patient&#39;s medical history and concomitant medications were not reported. The patient developed on day four (unknown date in 2021) redness with purplish lesions to the upper arm almost to antecubital. He was put on Levaquin by primary physician, the evaluation in his case was a cellulitis (unknown date in 2021). The reporter asked if the patient should get the second dose. The outcome of the events was unknown.; Sender&#39;s Comments: A possible contributory effect of suspect BNT162B2 on reported cellulitis cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>89</td>
                                    <td>2021-01-24</td>
                                    <td><strong>shingles</strong></td>
                                    <td>
                                        Developed pain on right side including arm down into hand and right shoulder.
                                        
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>89</td>
                                    <td>2021-01-24</td>
                                    <td><strong>injection site redness, injection site swelling</strong></td>
                                    <td>
                                        Redness and swelling at the injection site.
                                        
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>89</td>
                                    <td>2021-01-28</td>
                                    <td><strong>rash, itchy rash, hives</strong></td>
                                    <td>
                                        losing night time sleep; welts on his body; rashes on delicate parts of belly, buttocks, scalp which...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                losing night time sleep; welts on his body; rashes on delicate parts of belly, buttocks, scalp which were itchy/The rash gradually developed an itch; This is a spontaneous report from a contactable consumer (patient). An 89-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EH9899 and expiry date: 31Mar2021), via intramuscular route of administration on 30Dec2020 at 11:00 at a single dose on the left arm for COVID-19 immunization. The patient&#39;s medical history and concomitant medications were reported as none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 06Jan2021, a week after the injection, the patient experienced rashes on delicate parts of belly, buttocks, scalp which were itchy. The rash gradually developed an itch and he is now losing night time sleep. Patient stated that there were welts on his body on an unspecified date. He tried everything to stop the itch. He later stated there were objects across the counter that he tried, not prescription. One was alcohol and the other one was peroxide and a third one is Jergen&#39;s hand lotion and none worked. The outcome of the event itchy rash was not recovered, while unknown for the other events.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>89</td>
                                    <td>2021-01-28</td>
                                    <td><strong>tingling</strong></td>
                                    <td>
                                        patient complained of dizziness and vitals were taken and bp was 179/47, spo2 99% on room air with n...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                patient complained of dizziness and vitals were taken and bp was 179/47, spo2 99% on room air with numbness and tingling in left arm.  retake of blood pressure was 194/47 and pt was transported to urgent care via wheel chair.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>89</td>
                                    <td>2021-03-14</td>
                                    <td><strong>rash papular, itchy skin</strong></td>
                                    <td>
                                        body became very itchy and he was itchy all over; developing little red like pimples all different p...
                                        
                                        
                                            <a href="#" class="short-notes">Read more</a>
                                            <div class="full-notes">
                                                <div class="close-notes-bar"><a href="#" class="close-notes">Close</a></div>
                                                body became very itchy and he was itchy all over; developing little red like pimples all different parts of his body; itchy bumps/ little tiny pimples on his skin and it was very uncomfortable; little tiny pimples on his skin and it was very uncomfortable; This is a spontaneous report from a contactable consumer (the patient). An 89-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3249, expiry date 31May2021), via an unspecified route of administration (injection) in the left arm on 22Jan2021 (at the age of 89-years-old) as a single dose for COVID-19 immunization. The patient&#39;s medical history was not reported. The patient was on unspecified concomitant medications. The patient stated he has been taking the same medications for several years, and he has had no problems with those. The patient did not receive any other vaccines on the same day. The patient had his first Pfizer COVID-19 shot on 22Jan2021. He was due for his second shot on 12Feb2021. After he had the first shot, his body got itchy all over and it was still itchy. He also had little tiny pimples on his skin, and it was very uncomfortable. He was wondering if this was a known reaction to the product. He had no idea what to do to relieve the itching. He got the vaccine on 22Jan2021, and the itching started either the next day or two days after getting the vaccine. His body became very itchy, and he was itchy all over. He was developing little red like pimples all different parts of his body; itchy bumps. The itching and pimples having continued through to now, and it seemed to get even more itchy in the evening at bedtime. Last night (unspecified date), he had it on the top of his feet down there, on the top and in between his toes. Those itchy bumps were all over, and he did not know if that was the Pfizer shot.  The patient tried different anti-itch creams on it, and that relieved it for a while, but then it came back. He used clobetasol propionate, but it had not worked. They stopped itch for a while but then it does not help. He tried some just plain anti-itch cream (clarified as Gold Bond Anti-Itch Cream) to stop the itching. It stopped itch for a while, but then it did not help. He did not have to use the cream until 3-4 days. It was some prescription from the doctor, but it was for his wife. He tried it, but it did not do anything. The patient stated the injection itself did not give him any problems. The patient was wondering whether he should take the second shot if this one gave him so much trouble. The clinical outcome of discomfort was unknown. The outcome of the other events was not recovered.
                                            </div>
                                        
                                    </td>
                                </tr>
                            
                                <tr>
                                    <td>89</td>
                                    <td>2021-03-16</td>
                                    <td><strong>injection site pain</strong></td>
                                    <td>
                                        Site: Pain at Injection Site-Mild
                                        
                                        
                                    </td>
                                </tr>
                            
                            </tbody>
                        </table>
                    
                </section>
                
<footer class="page__meta">
    <p class="page__date"><strong><i class="fas fa-fw fa-calendar-alt" aria-hidden="true"></i> Updated:</strong> <time datetime="2021-04-24">April 27, 2021</time></p>
</footer>

            </div>
        </article>
    </div>
</div>


    <div class="page__footer">
        <footer>
            <div class="page__footer-follow">
                <ul class="social-icons">
                    <li><a href="https://github.com/thehungrysmurf/vax" rel="nofollow noopener noreferrer"><i class="fab fa-fw fa-github" aria-hidden="true"></i> GitHub</a></li>
                </ul>
            </div>
            <div class="page__footer-copyright">
                &copy;2021 KnowYourVaccine
            </div>
        </footer>
    </div>


<script>
    var categories = document.getElementsByClassName("category-toggle");
    for (var i = 0; i < categories.length; i++) {
        var el = categories[i];
        el.onclick = function(event) {
            event.preventDefault();
            var ul = this.parentElement.getElementsByTagName("ul")[0];
            if(ul.className == "") {
                ul.className = "category-open";
            } else {
                ul.className = "";
            }
        }
    }

    var url = window.location.toString();
    var menu = document.getElementsByClassName("toc__menu")[0]
    var symptomGroups = menu.getElementsByTagName("a");
    for (var i = 0; i < symptomGroups.length; i++) {
        var link = symptomGroups[i];
        if(link.href == url) {
            link.parentNode.parentNode.className += " category-open";
        }
    }

    var ellipsis = document.getElementsByClassName("short-notes");
    for (var i = 0; i < ellipsis.length; i++) {
        var el = ellipsis[i];
        el.onclick = function(event) {
            event.preventDefault();
            var td = this.parentElement;
            if(td.className == "") {
                td.className = "open-notes";
            } else {
                td.className = "";
            }
        }
    }

    var close = document.getElementsByClassName("close-notes");
    for (var i = 0; i < close.length; i++) {
        var el = close[i];
        el.onclick = function(event) {
            event.preventDefault();
            var td = this.parentElement.parentElement.parentElement;
            td.className = "";
        }
    }
</script>
</body>
</html>